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Foreword
Unconsciously to myself, I looked at a film of sand I had picked up on my hand, when I 
suddenly saw the exquisite beauty of every little grain of it; instead of being dull, I saw 
that each particle was made up on a perfect geometrical pattern, with sharp angles, from 
each of which a brilliant shaft of light was reflected, while each tint crystal shone like a 
rainbow.
Then suddenly, my consciousness was lighted up from within and I saw in a vivid way 
how the whole universe was made up of particles of material which, no matter how dull 
and lifeless they might seem, were nevertheless filled with this intense and vital beauty. 
For a second or two the whole world appeared as a blaze of glory. When it died down, it 
left me with something I have never forgotten and which constantly reminds me of the 
beauty locked up in every minute speck of material around us.
Aldous Huxley 
1956, Heaven and Hell
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Abstract
Bacterial superantigens are potent T cell stimulatory protein molecules produced by 
Staphylococcus aureus and Streptococcus pyogenes. Their superantigenic activity can 
be attributed to their ability to cross-link MHC class II molecules with T cell receptors 
to form a tri-molecular complex. Unlike conventional antigen, they are not processed 
internally by antigen presenting cells (APC), and are thus not displayed as peptide 
antigen in the peptide-binding groove of the MHC class II molecule. Superantigens bind 
to APCs on the outside of MHC class II molecule and to T cells via the external face of 
the T cell receptor (TCR) V p element. Each superantigen interacts with a specific Vp 
region of the TCR, and with a specific subset of the total TCR Vp elements available 
Therefore, superantigens stimulate populations of T cells in a V p specific, non-MHC 
restricted manner. This enables them to stimulate a far greater proportion of resting T 
cells compared to conventional antigen. Using X-ray crystallography, the structures of 
several superantigens both in native and mutant forms have been elucidated. This has 
enabled us to characterise the regions of these proteins that interact with the immune 
system and govern their specificity and potency; namely the MHC class II binding 
regions and the T cell receptor binding regions. Firstly, this study has investigated the 
role of zinc ions as high affinity MHC class II binding sites for superantigens by 
determining the crystal structure of SpeAl in complex with zinc. Secondly, the crystal 
structure of SEB variant Thr 112 Ser has served to further characterise the TCR binding 
site of the superantigen family. Thirdly, by solving the crystal structures of three 
TSST-1 mutants -  Tyr 13-Ala, His 141-Ala, and Tyr 174-Ala this study has addressed 
the structural and functional significance of these three residues on TCR recognition for 
the toxin. Finally, by producing SEC2 mutants with substitutions within its zinc binding 
site ( His 118-Ala and Hisl 18:122-Ala) an attempt has been made to structurally assess
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the functional contribution of these residues to the topology of the SEC2 zinc binding 
site and the involvement of these residues in interacting with MHC class II molecules. 
Ultimately, this has also allowed the identification of several mechanisms by which this 
family of proteins could elicit an immune response. Although these mechanisms share 
common features throughout the family, each superantigen has adopted a unique 
combination of subtle structural differences to optimise its interactions with both MHC 
class II molecules and T cell receptors.
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Abbreviations
A -  Angstrom lO^nm.
APC -  Antigen presenting cell.
B-factor -  Thermal parameter.
MHC -  Major Histocompatibility complex.
PEG -  Polyethylene glycol.
PBMC -  Peripheral blood mononuclear cell. 
r.m.s -  Root mean square.
SAg -  Superantigen.
TSS -  Toxic shock syndrome
TSST-1 Toxic shock syndrome toxin - 1
SEA -  Staphylococcal enterotoxin type A.
SEB -  Staphylococcal enterotoxin type B.
SEC -  Staphylococcal enterotoxin type C.
SED -  Staphylococcal enterotoxin type D.
SEE -  Staphylococcal enterotoxin type E.
SEH -  Staphylococcal enterotoxin type H.
SpeA -  Streptococcal pyrogenic exotoxin type A. 
SpeC -  Streptococcal pyrogenic exotoxin type C. 
TCR -  T Cell receptor.
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Chapter 1 An introduction to protein crystallography
X-ray crystallography
The knowledge of accurate molecular structures provided by X-ray crystallography can 
provide answers to many of the questions faced by the modem structural biologist, from 
global folds of a protein to atomic detail of inter- and intra-molecular bonding that may 
help identify protein interactions and enzymatic mechanisms (Rhodes, 1993). Indeed, it 
can be said that underlying principle of biological function is biological structure. 
Structural biology is an ever-evolving state-of-the-art technique; over the years the 
advent of increasingly faster computers, improved X-ray technology- both in terms of 
machinery and our understanding of the behaviour of X-rays has lead to many 
improvements in the speed and accuracy of structure solution (Helliwell, 1992). In turn, 
the information from the many completed molecular structures has allowed us to further 
improve our interpretation of X-ray diffraction data.
In this section the various stages of determining the structure of a given protein will be 
discussed. These stages are:
• Availability of pure protein
• Crystallisation of the pure sample
• Selection of the appropriate data collection conditions
• Determination of the unit cell parameters
• X-ray data collection to a given resolution
• Solution of the crystallographic phase problem
• Interpretation of the electron density map
• Refinement of the molecular model against the observed data
• Structure analysis and validation
• Structure deposition (atomic co-ordinates and structure factors) with PDB.
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Further to this, the basic principles of X-ray diffraction will be discussed along with an 
outline of the kinds of x-ray, computer hardware, software and detectors used to carry 
out data collection.
Protein purification
The aim of protein purification for crystallisation trials is to produce a pure (> 99%), 
correctly folded, monodispersed, structurally homogenous protein sample. A complete 
review of methods for protein purification is beyond the scope of this work, however 
certain aspects should be considered when purifying proteins for crystallography.
These include:
• Protein source -  wild type or recombinant
• Expression system
• Fusion proteins and cleavage of tag
• Purification method
• Assessment of purity.
The choice of protein source, expression system and to some degree, purification 
method can have a profound effect on the amount of protein produced/recovered. As 
protein crystallisation requires a relatively large amount of pure material, these 
processes must be optimised. The purification method and assessment of purity are 
important as lack of purity in a sample may lead to (/) complete failure to crystallise (if) 
the production of only small crystals or (iii) large crystals that do not diffract X-rays 
well. Contaminating species, which are able to satisfy only a portion of the bonding 
interaction necessary to propagate the lattice, will reduce crystal formation. 
Heterogeneity in the protein solution will at best reduce the pool of available material in 
the crystallisation medium which can be incorporated into the lattice. Micro­
heterogeneity in the protein of interest may be as much of a problem to crystallisation as
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contamination with an unrelated protein molecule as the accumulated defects at the 
crystal surface which result are believed to play a role in limiting crystal size. 
Incorporation of protein molecules other than that of interest into the crystal will result 
in increased disorder within the crystal producing poor diffraction.
Crystallisation of proteins
A crystal is an orderly three-dimensional array of molecules held together by non- 
covalent interactions. The aim of a crystallisation experiment is to produce crystals of 
diffraction quality. Ideally, a crystal should be homogenous and well ordered, of 
reasonable size and free from flaws such as cracks. The apparently simple task of 
crystallising any given protein is considered to be the limiting step to protein structure 
determination. The process involves the ‘controlled’ precipitation of the protein from 
solution to form ordered crystals. This process begins with the association of protein 
aggregates whose intermolecular contacts resemble those found in the final crystal 
(Salemme et al., 1988). Eventually these aggregates reach the critical nuclear size and 
growth proceeds by the addition of molecules to the crystalline lattice. The processes of 
nucleation and crystal growth both occur in supersaturated solutions where the 
concentration of protein exceeds its equilibrium solubility value (see Figure 1.1). 
Supersaturation is a function of the protein and factors which affect its solubility. It can 
be achieved at high protein concentrations and by altering factors that affect protein 
solubility. These factors include: additives such as alcohols; hydrophilic polymers such 
as polyethylene glycol and addition of detergent. These agents are commonly known as 
precipitants. Salt concentration, pH and temperature also have an affect on protein 
solubility. Proteins are usually less soluble at both high and low salt concentrations, so 
crystallisation strategies that either include or exclude salt could induce crystallisation. 
The supersaturation requirements for nucleation and crystal growth differ. The phase
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diagram in Figure 1.1 shows the supersaturation zone as being further divided into 
regions o f higher supersaturation (the labile zone) where both growth and nucleation 













Figure 1.1: Phase diagram of crystal growth. Nucleation and crystal growth occur in supersaturated 
solutions where the concentration of protein exceeds its equilibrium solubility value.
There are several variants o f the vapour diffusion technique, all o f which are based on 
the principle o f diffusion through the air from a high concentration o f soluble protein to 
a reservoir o f precipitant. Nucleation occurs through the increase in protein 
concentration through dehydration-driven reduction o f solution volume caused by 
equilibration of water vapour from the protein-containing drop to a more hygroscopic 
reservoir solution. Figure 1.2 shows the experimental set-up for a hanging drop, 
whereby the protein solution is suspended in a drop on a coverslip above a reservoir o f  
precipitant (also known as mother-liquor) in a sealed system. Once nucleation occurs, 
the solution remains highly supersaturated, so that nucleation and rapid crystal growth 
can occur simultaneously. The hanging drop vapour diffusion technique is perhaps the 
most widely used method for protein crystallisation. The fact that a majority o f the
5
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drops set up in a typical crystallisation trial do not produce crystals suggests that 
although a high degree o f nucleation supporting supersaturation may be achieved, it is 
not sustained during the course o f the experiment. Many factors, including the decrease 
in macromolecule concentration due to formation o f nuclei or precipitates, 
macromolecular incorporation into growing crystals, or macromolecular denaturation at 








protein solution  
and mother liquor.
S i1iconised  
cover s l ip  
sealed to  well 
with vacuum
grease.
Figure 1.2: Experimental set-up for the hanging drop vapour diffusion technique
Because the specific supersaturation requirements for nucleation and growth differ from 
protein to protein, a convenient starting point for crystallisation is to use a screen o f the 
most commonly used precipitants, salts and pHs. Such screens (e.g. Magic 50, Hampton 
research crystal screen, PEG/ion screen and others) contain approximately 50 separate 
crystallisation conditions. The temperature o f crystallisation can also be varied so as 
best to control the precipitation and produce better crystals. Once a suitable condition 
has been found, optimisation o f  the condition should be carried out in order to further
6
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improve the quality of the crystals produced. If optimisation fails to yield diffraction 
quality crystals, a number of techniques such as seeding can be employed. A seed (a 
small crystal of the protein to be crystallised from a previous trial) provides a template 
on which further molecules can assemble in order to produce a crystal of a more 
favourable size. The seed is transferred into a new drop under conditions suitable for 
growth but ideally, not further nucleation.
Principles of X-ray crystallography
X-rays are electromagnetic radiation, which are diffracted by even the smallest 
molecules. Even though individual atoms diffract X-rays, it is still not possible to 
produce a focussed image of a molecule.
Figure 1.3 illustrates the collection of X-ray diffraction data. A crystal is mounted on 
the goniostat between the X-ray source and the X-ray detector in the direct path of the 
X-ray beam. The crystal diffracts the source beam into many discrete beams each of 
which produces a distinct spot in an orderly array. These spots are called reflections 
because they emerge from the crystal as if reflected from planes of atoms. These 
reflections are measured using a detector. Several types of detectors are used such as 
CCD (charge coupled device), Image plate and the area detector.
7
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Diffracted
X -r a y s
C r y s ta l
R e f l e c t io n s
Figure 1.3: Schematic representation of the data collection set up.
The greater the intensity o f the X-ray beam that reaches the detector at a particular 
position the darker the reflection. The position and intensity o f each reflection is 
precisely measured by the detector and is transmitted in digital form to the computer for 
analysis. The position o f the reflection can be used to obtain the direction in which that 
particular beam was diffracted by the crystal. The intensity o f the reflection is calculated 
by measuring the optical absorbance o f the spot. This gives a measure o f the strength of  
the diffracted beam that produces a particular spot. The position o f each reflection can 
be assigned three co-ordinates or indices in reciprocal space o f the diffraction pattern 
designated h, k, and /. The central beam position is taken as the origin and assigned the 
co-ordinates (h, k, I) = (0, 0, 0) or hkl = 000. This reflection is not measured as it is 
obscured by the direct beam. The other reflections are assigned whole-number co­
ordinates counted from this origin. Thus, the parameters we can measure and analyse 
are the position hkl and the intensity Ihki o f  each reflection. The position o f each
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reflection is related to the angle by which the diffracted beam diverges from the source 
beam. For a unit cell of known dimensions, the angle of divergence uniquely specifies 
the indices of a reflection.
Bragg’s law
Bragg’s law predicts the angle of reflection of any diffracted beam from specific atomic 
planes whereby:
rik =2d sin 0
Where d is the interplanar spacing of that set of planes, X is the wavelength of the X- 
rays and n is an integer. For a fixed X, the closer the separation of the planes the larger 
the value of 0, the diffraction angle (see Figure 1.4a). The geometrical construction by 
Ewald can be used to illustrate the nature of space and diffraction geometry. There are 
two conditions for a diffracted beam, the first on the frequency (wavelength) and the 
second on the wavevector. Where k denotes the wavevector (k = 1/X) and © the 
frequency of the incident beam; k’ and ©’ refer to the scattered beam. Then
a) The scattering is elastic, so that the energy of the X-ray quantum is conserved:
hco' - /?©
where h= h/2nand h is Planck’s constant.
By the dispersion relation for electromagnetic waves in free space we have 2mo ' = ck’ 
and 2mo = ck, so;
k ' = k
b) The scattering condition on the wavevector is that 8k = G 
(where G= ha* + kb* +lc*), or
k’ = k + G
9
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This leads to the geometric construction shown in Figure 1.4b. The points in the 
diagram are reciprocal lattice points of the crystal. The vector k is drawn in the direction 
of the incident X-ray beam and it terminates at the origin of reciprocal space (point A)
A sphere of radius k = 1/A, is drawn about the crystal position (which is where k starts). 
A diffracted beam will be formed if this sphere intersects any other point on the 
reciprocal lattice. As drawn, the sphere intercepts a point (B) connected with the end of 
k by a reciprocal lattice vector G. The diffracted X-ray beam is in the direction k \  This 
is a graphical way of saying that:
rik =2d sin 0
In other words, the process of diffraction from a crystal can be considered to be the 
rotation of a 3-D grid of points around an origin so that they diffract where they 
intersect the surface of a sphere centred on the crystal. The origin of this rotation is a 
point 1/A. away from the crystal in a direction along the vector of the incident X-rays.
10





Figure 1.4a: Schematic representation of Bragg’s law. 
1.4b: The Ewald’s Geometric construction.
11
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Unit cell
The unit cell is the smallest and simplest volume element that is completely 
representative of the whole crystal. We can imagine the crystal as being composed of a 
repeating array of the unit cell stacked beside and on top of each other like boxes. The 
image obtained in a crystallography experiment is representative of the average unit cell 
in the crystal. The location of an atom within the cell is given by a set of three- 
dimensional cartesian co-ordinates, x, y and z. One of the vertices (a lattice point, or any 
other convenient point) is used as the origin of the unit cells co-ordinate system and is 
assigned the co-ordinates x = 0, y = 0, z = 0 (0,0,0) (see Figure 1.5a).
The dimensions of the unit cell are designated by six numbers: the lengths of the three 
unique edges a, b and c; and three unique angles a , p and y (Figure 1.5b). A cell in 
which a ^  b ^  c and a  ^  p ^  y is called triclinic, if a ^  b ^  c and a  = y = 90°, and p 
>90°, the cell is monoclinic. If a = b, a  = p = 90°, and y = 120°, the cell is hexagonal.
For cells in which all three cell angles are 90°, if a = b = c, the cell is cubic, if a = b ^  c 
the cell is tetragonal, if a ^  b ^  c, the cell is orthorhombic. In the orthogonal co-ordinate 
system, the a edge of the cell is parallel to the x  axis, b parallel to y, and c parallel to z. 
Thus the atom co-ordinates in real space x, y  and z describing real special positions of 
the atoms in the unit cell, can be related to the position of a reflection in reciprocal 
space described by its indices (hkl) (Blundell and Johnson, 1976).
12
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(A)
A tom  poMlion:
O r b* in
(B)
Figure 1.5a: The atomic position within the unit cell. 
1.5b: The unit cell dimensions and angles.
Chapter 1 An introduction to protein crystallography
X-ray sources
Laboratory sources of X-rays such as sealed tubes and rotating anode tubes accelerate 
electrons to a voltage o f40-50 kV at a metal target such as copper which has a 
characteristic wavelength copper Ka radiation (X = 1.5418 A). The X-rays produced are 
then filtered by a monochromator and focused by curved mirrors. Monochromators are 
made from either nickel or a single crystal. They effectively remove absorbed radiation 
and have no contribution to the diffraction pattern. The mirror then deflects the focused 
X-rays through a low angle which increases the brilliance of the beam. Brilliance is 
defined as the fraction of flux (number of photons emitted) over the angle through 
which radiation is emitted multiplied by the cross sectional area of the source (Rhodes, 
1993).
However, the nature of protein crystallography is better suited to synchrotron radiation 
(SR). Particle accelerators were originally developed for high-energy physics research 
into the subatomic structure of matter. The synchrotron radiation, which was produced 
in circular electron accelerators (‘synchrotrons’) was little more than an annoying by­
product of this process; a loss of energy from the system. Through the increase in use of 
SR the process of its production and properties has been fine-tuned. As a result modem 
SR is of high flux (large number of photons), high brightness (well collimated), high 
brilliance (small source size and well collimated), tuneable, polarized, defined time 
structure (fine time resolution) with an exactly calculable spectra. SR allows the user to 
measure the highest possible resolution data, to study crystals with large unit cells and 
to collect data from crystals too small to be of any use with conventional sources 
(Daresbuiy user information, 2001). Synchrotron light is produced when an electron 
beam travelling at close to the speed of light is accelerated in a magnetic field .The light 
covers a broad spectrum of the electromagnetic spectrum, from infrared through to hard
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X-rays. X-rays produced at synchrotron sources are much more intense than those 
produced from a conventional laboratory source. This allows experiments to be carried 
out in a much shorter time. The particles are accelerated by a series of devices to as 
close to the speed of light as is possible (99.999997% the speed of light) and stored in a 
storage ring. The first step in producing SR at the Synchrotron Radiation Source (SRS) 
Daresbury (U.K) is the linear accelerator (Linac), which accelerates particles from 0.511 
MeV to 12 MeV and injects them into the booster ring. Here they are accelerated further 
to 600 MeV before being transferred to the storage ring where they are further 
accelerated to 2000 MeV. The sixteen-dipole magnets keeping the electron beam on its 
circular path all produce a broad spectrum of wavelengths, with the most intense output 
in the soft X-ray region (~4xl O'10 m). Insertion devices between the dipole magnets 
further tune and enhance the beam. The first such device is an ‘undulator’ magnet. The 
undulator is formed from a periodic array of permanent magnets that are arranged to 
gently wave the electron beam in a sine-like path through the magnets length. 
Synchrotron light results from each undulation, and constructive interference between 
these consecutive emissions gives a very bright and narrow beam of light (high 
brilliance). The second type of insertion device, a ‘wiggler’ magnet also known as a 
‘wavelength shifter’, so called because it shifts the most intense output further into the 
hard X-ray region. These are superconducting magnets which force the beam to take a 
‘hairpin’ turn, causing an enormous amount of acceleration and generating very short 
wavelengths of light. The beam is then carried from the storage ring to the experimental 
area through a high vacuum beamline. Within these beams are focussing mirrors to 
concentrate the synchrotron light at the sample (Helliwell, 1992).
15
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Data collection
Crystals can be mounted in one of two ways, depending on the conditions of data 
collection. Room temperature data are collected from crystals mounted in thin walled 
glass capillaries. The crystal is sealed in the capillary in a small amount of the mother 
liquor from the crystallisation process. Glass has minimal absorption of the scattered X- 
rays and gives low background which can be corrected for. A second method of crystal 
mounting is used for collecting data at cryogenic temperatures. Crystals are usually 
picked directly from the hanging drop with a loop of fine nylon or glass fibre. The 
crystal is then transferred to a second solution identical to that of crystallisation except 
that a volume of the water in the solution is replaced with a suitable cryoprotectant such 
as glycerol or polyethylene glycol. The crystal is then removed by from the solution 
using the loop which holds it in place by surface tension and frozen immediately in a 
stream of nitrogen gas. The temperatures used typically in the range of 80 to 100°K.
The choice of cryoprotectant is of great importance and varies depending on the crystal. 
The ideal cryoprotectant should surround the crystal with a thin ‘amorphous glass’ 
which prevents the formation of ice crystals which interfere with the diffraction pattern 
of the crystal. The practice of cryo-crystallography is a relatively new method in 
modem crystallography. The benefits of collecting data at such low temperatures are 
numerous: (z) Primary and secondary radiation damage is reduced, increasing the 
lifetime of the crystal, in turn this often allows the collection of a data set from one 
single crystal which generally has improved quality compared to a data set collected 
from several crystals, (it) Manipulation of smaller, more fragile crystals is permitted due 
to a reduction of mechanical stress on the crystal, (zzz) The low temperature reduces the 
thermal parameters and allows measurement at higher resolution. New experimental 
techniques have been established due to the use of cryogenic temperatures; for example
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catalytic mechanisms can be deduced by solving the structure of enzymes in complex 
with reaction intermediates. The low temperature of data collection slows down the 
reaction mechanism significantly to allow a ‘movie of catalysis’ to be seen. (Garman 
and Schneider, 1997; Rodgers, 1994).
Unfortunately, cryogenic data collection is not ideal. Unfavourable changes in the 
nature of the crystal may be observed. The most common problem is increase in 
mosaicity. The freezing of the crystal alters the alignment of each unit cell with its 
neighbours resulting in an amount of disorder. This causes the individual reflections to 
be more diffuse rather than sharp spots. However, this can be corrected for while 
processing the data. Unit cell volume changes as the temperature is lowered causing 
non-isomoiphism between crystals. This becomes a problem when collecting native 
and derivative data sets. The cryoprotectant may interact with the protein causing 
conformational changes and may also interfere with ligand binding studies. If the 
cryoprotectant is not optimal, ice may form within the loop and a diffraction pattern for 
ice is produced which can obscure the data from the protein crystal.
Mounting and alignment of crystals
Once the data collection method has been decided upon the crystal must be mounted 
and aligned with the X-ray beam. First the crystal is mounted on the goniometer. This is 
a device that allows the orientation of the mounted crystal to be set precisely.
Alignment is carried out by rotating the crystal in one direction; usually perpendicular 
to the beam and checking to make sure the crystal is in the beam path at 0,90, 180,270° 
of rotation. The initial orientations are determined by physical examination. Well- 
formed crystals show distinct faces that are parallel to unit cell edges, and the initial 
diffraction pattern should be obtained by placing a crystal face perpendicular to the
17
Chapter 1 An introduction to protein crystallography
beam. Preliminary examination of the diffraction pattern allows determination of unit 
cell dimensions and internal symmetry. The diffraction limit of the crystal can be 
deduced by observing the resolution where a minimum of one third of the possible 
reflections are distinguishable from background. It is important to collect data to the 
highest resolution the quality of the crystal will allow. The more reflections that can be 
used in the integration, reduction and refinement the higher the quality and validity of 
the structure produced. The spot size and shape (mosaicity) in the direction of rotation 
should be taken into account when setting the rotation angle as well as the quality of the 
crystal and the desired resolution. Programs such as Strategy in MOSFLM (Leslie, 
1992) and predict can provide a data collection strategy based on an initial diffraction 
pattern. It is important to note that data cannot be collected in the area of reciprocal 
space near to the rotation axis (Dauter, 1997). This ‘blind region* results from the fact 
that some reciprocal lattice points do not cross Ewald’s sphere surface throughout a 
360° rotation. It should also be noted that there are further areas where data cannot be 
collected due to the Lorentz correction being too high. Lorentz correction is dependent 
on the geometry of the detector and is used in order to account for the amount of time a 
reflection spends under diffracting conditions while being rotated through the Ewalds 
sphere. Less intensity will be seen for those reflections that would spend less time in the 
Ewald’s sphere (i.e. under diffraction conditions) than for the slower moving reflections 
that spend longer under diffraction conditions. The amount of data required for a 
complete data set depends on the crystal system. The higher the symmetry, the fewer 
degrees of rotation and therefore less number of images need to be collected in order to 
have complete data.
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Data integration and reduction
After data collection, the raw intensities must be processed to improve their consistency 
and to maximise the number of measurements that are sufficiently accurate to be used. 
The processing of data involves the indexing of each reflection from each diffraction 
image. There are several computer programmes that automate this process, the mGst 
commonly used being the HKL package (Otwinowski and Minor, 1997) and MOSFLM 
(Leslie, 1992, CCP4,1994). The HKL program suite consists of: (i) DENZO -  which 
carries out autoindexing, refinement and integration, (ii) XdisplayF -  for image display 
and measurement, (iii) Scalepack- for data scaling. With the increased speed of modem 
computing and improvements in detector readout time, data collection and processing is 
often a synchronous task. As such the suite can initially be used to index the first few 
diffraction images and assess the data being collected in near real time. This allows the 
user to assess the quality of the data that can be collected and indicates whether it is 
worthwhile proceeding with data collection with that particular crystal.
Autoindexing using DENZO involves the determination of a standard lattice. A 
complete search of all possible indices of all reflections is performed. When the 
program finds values (integers) of one index (e.g. h) for all reflections, this is equivalent 
to having found one real-space direction of the crystal axis (e.g. a). The search for real 
space vectors is performed by Fast Fourier Transform (FFT) and takes advantage of the 
fact that finding all values for one index for all reflections is independent of finding all 
values of another index. After the search for real space vectors is completed, the 
program finds the three linearly independent vectors with minimal determinant (unit 
cell volume) that would index all of the observed peaks and reduces the cell by 
conversion into a standard cell according to the International Tables for 
Crystallography, which contain an index for standard space group and symmetry
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classification. The highest symmetry lattice with minimal distortion is selected and 
processing of the remainder of the data proceeds using the initial estimates as a 
reference.
A complete set of measured intensities often includes distinct blocks of data obtained 
from several crystals or different areas of the same crystal. Because of variability in the 
diffraction quality between crystals and changes in intensity of the X-ray beam over the 
time-course of data collection one cannot assume that the absolute intensities are 
consistent from one data block to the next. For this reason, the indexed reflections must 
be scaled. Scaling is the comparison of reflections of the same index that were measured 
from more than one crystal or at a different beam intensity. The intensities of identical 
reflections from these data blocks are then scaled to give an average intensity relative to 
background levels. The program SCALEPACK (Otwinowski and Minor, 1997) from 
the HKL suite allows the user to analyse the quality of the diffraction data statistically. 
There are several ways to assess data quality. Firstly, data completeness (the number of 
unique reflections measured divided by the number of complete reflections possible) 
indicates how inclusive the data is in each resolution bin. Secondly, the Rmerge value, 
which is the agreement between symmetry related reflections given by:
Rmerge ('/) = ^i\(Jh ~ hi)| xlOO
Where h  is the weighted mean measured intensity of the observations hi in which the 
intensities of the symmetry related reflections are compared, thus Rmerge is the 
measurement of the disagreement (h, hd- Finally, the ratio of intensity over the error of 
intensity (I/al) is in effect the signal to noise of the data. As such it defines a resolution 
limit because data at high resolution with a I/al of less than two is not reliably 
distinguishable from background and cannot be used, a l of a reflection intensity is an
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estimate of the accuracy of an individual measurement taking into account height, 
variance and the number of times the reflection was measured.
In practice, it is a good idea to collect as much data as possible in order to reduce the 
errors in the observed data.
MOSFLM (Leslie, 1992) consists of a graphical user interface through which the 
process of data processing can be carried out. Unlike DENZO it does not use key word 
input so is relatively straightforward to use. The end result of data processing with 
MOSFLM is an MTZ file of reflection indices with their intensities and standard 
deviations. The MTZ file is then passed onto the program Scala for scaling and 
merging. Both the HKL suite and MOSFLM/Scala perform the same tasks and use the 
same statistical assessment of scaled data.
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Structure factor and the Phase problem
The vector (amplitude and phase) representing the overall scattering from a particular 
set of Bragg planes is termed the structure factor (F). The structure factors for the 
various points on the crystal lattice correspond to the Fourier transform of the electron 
density within the unit cell and vice-versa. (Blundell and Johnson, 1976)
Whole unit cell
I
F (h,k,l) = v C o  ( - 0  f-o  p0y>,z).exp[27t/(h x + + lz)].dxdydz
t t
A reflection Electron density
All reflections Phase
U I




Unfortunately, the diffraction pattern produced by the crystal contains no information 
about the phase o f the diffracted beam that produces each reflection. The reasons for 
this become clearer when we look more closely at the nature o f X-ray diffraction. When 
waves are diffracted from a crystal, they give rise to reflections. Each reflection 
corresponds to a point in the reciprocal lattice and represents a wave with an amplitude 
and a relative phase. In reality photons are reflected from the crystal in different 
directions with a probability proportional to the square o f the amplitude o f this wave. 
We count the photons, and we lose any information about the relative phases o f the 
diffraction. This is known as the ‘phase problem’. This problem can be solved using
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several different methods: (/) Molecular replacement (MR). By determining the correct 
orientation and position of a molecule in the unit cell using a previously solved structure 
as a 'search model’. This model can then be used to calculate phases (Rossman, 1972). 
(if) Isomorphous replacement (IR) provides indirect estimates of the protein phase 
angles by observing the interference effects of the intensities on scattered beams by a 
heavy atom marker (Ke, 1997) (Blundell and Johnson, 1976). (iii) Anomalous scattering 
in which the scattering information of an atom whose absorption frequency is close to 
the wavelength of the source beam produces phase information. Multi-wavelength 
anomalous dispersion, requires intensity measurements at several wavelengths, while 
resolved anomalous scattering requires intensity measurements at one wavelength 
(Hendrickson, 1991). Both (if) and (iii) can be used when solving a novel structure for 
which there are no homologous structures or when molecular replacement methods fail 
to produce a satisfactory solution.
Molecular replacement
The basic principle of molecular replacement is to determine a rotation matrix, [C], and 
a translation vector, d_, to apply to the co-ordinates of the search model xto  solve the 
target structure x \  Hence,
x’ = [C]x + d
The problem is six dimensional because it involves three rotational and three 
translational parameters. This is simplified by separating the search into two stages, 
namely the rotation and translation searches.
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The search model is placed in tentative positions in the unit cell and agreement between 
the calculated and observed structure factors for each placement is assessed. Several 
factors can affect the success of this procedure. Firstly, The homology between the 
search model and the actual molecule should be high. Secondly, the quality and 
completeness of the data should be as high as possible. Other factors include the relative 
size of the search model compared to the unit cell and the how the agreement between 
the model and experimental data are assessed.
Several programs are available for solving structures by molecular replacement.
AMoRe (Automated Molecular Replacement), by far the most commonly used, is part 
of the CCP4 program suite (CCP4,1994; Navaza, 1994; Navaza and Saludjian, 1997). 
AMoRe consists of a set of programs to calculate and assess the rotation function 
(ROTING) and translation function (TRIANG). Peak height and correlation coefficient 
are used to assess the rotation and translation, a map is calculated (FFT) and the model 
is then submitted for rigid body refinement (FITING).
Isomorphous replacement and anomalous scattering
In isomorphous replacement, the idea is to make a change to the crystal that will perturb 
the structure factors and, by the way that they are perturbed, to make some deductions 
about possible phase values. Heavy atoms are introduced to the crystal through 
soaking, changing the scattered intensity significantly by disproportionately 
contributing to the overall intensity. All the electrons in the heavy atom will scatter 
essentially in the same phase. This means that different heavy atoms contribute to the 
scattered intensity in proportion to the square of the number of electrons they contain. 
For example, a uranium atom contains 15 times as many electrons as a carbon atom, so 
its contribution to the intensity will be equivalent to that o f225 carbon atoms. As a
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result, the change in intensity from the addition of just one uranium atom to each 
molecule of protein in the crystal is easily measured. In practice, diffraction data is 
collected for both native and heavy atom soaked crystals. The differences in scattered 
intensities will largely reflect the scattering contribution of the heavy atoms, and these 
differences can be used to plot a Patterson map. Because there are only a few heavy 
atoms present, such a map should be relatively easy to deconvolute. Once the positions 
of the heavy atoms in the crystal are known, we can calculate their contribution to the 
structure factors. If the heavy atom doesn’t change the rest of the structure, then the 
structure factor for the derivative crystal (Fph) is equal to the sum of the protein 
structure factor (Fp) and the heavy atom structure factor (Fh), or
Fph«Fp +  Fh
By producing a Harker construction we are able to calculate the two possible values for 
Fp that agree with both the measured amplitudes and with the heavy atom model. By 
preparing a second derivative crystal with heavy atoms that bind to other sites it is 
possible to resolve this twofold phase ambiguity as only one phase choice will be 
consistent with all the observations from both derivatives and the native crystal.
If the X-ray photon energy is close to the transition energy of electrons from certain 
atoms (e.g heavy atoms) in the structure there will be a small shift in phase and 
amplitude. This is known as anomalous scattering. The effect of anomalous scattering is 
to make the amplitude of the Friedel mates different. If we have a model for the 
anomalous scatterers in the crystal, we can draw vectors for their contribution to the 
structure factors for the Friedel mates and construct a Harker diagram. By collecting 
data at several wavelengths near the absorption edge of an element in the crystal, we can 
obtain phase information analogous to that obtained from MIR. This technique is called 
MAD (multiple-wavelength anomalous dispersion). The most common use of MAD is
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to introduce selenomethionine into the protein structure in place of a methionine. The 
selenium atoms have a strong anomalous signal at wavelengths that can be obtained 
from synchrotron sources.
Refinement
The correctly positioned molecule(s) from molecular replacement, MIR or MAD must 
now be refined in order to produce a valid representation of the crystal structure. The 
model will differ from the actual molecule in the crystal in terms of amino-acid 
sequence and main chain and side chain conformation. The objective of crystallographic 
refinement is to optimise the agreement between the atomic model with the observed 
data within the bounds of accepted chemical geometries. Because of the poor 
observation: parameter ratio typical of macromolecular crystallography, it is possible 
to overfit the data. So, validation is of paramount importance. There are different 
aspects to validation. Some types of validation look at the fit to the diffraction data. The 
agreement of observed and calculated structure factors is often measured with the 
traditional R-factor, which is the average fractional disagreement:
R=S(If„-fJ)/sIfJ
The problem of overfitting the data can be avoided by excluding 5-10% of the data from 
refinement (test set). The test data are used to calculate R-free, which is computed in the 
same way as the conventional R-factor but using only that subset of data. There is no 
pressure to overfit R-free, which leads to a more valid model. This idea, introduced by 
Axel Brunger is known as cross validation (Briinger et al., 1992).
Crystallographic refinement can be formulated as a search for the global minimum of 
the target function (Brunger et a.l9 1997)
E = Echem Wxray Exray
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Where EChcm is the empirical potential energy function of all atomic positions, 
describing covalent (bond length, bond angle, torsion angle, chiral centres, and planarity 
of aromatic rings) and non-covalent (van der Waals, hydrogen bonding, and 
electrostatic) interactions, w ^y  is a weight chosen to balance the forces arising from 
each term. The choice of y can be critical: too large, and the refined structure will 
show deviations from ideal geometry; too small and the refined structure will not satisfy 
the diffraction data.
Echem = H h ( r  -7*o)2 +  (0-0q)2bonds angles
+ 2  kj£os(n</>-d) +  2  ■ ®o)2dihedrals chiral, planar
+ 2  (ar12 + br6 + c r -1)atom pairs
The parameters of the empirical potential energy EChcm are inferred from experimental 
and theoretical investigations. Additional restraints and constraints such as fixing atom 
positions, bond lengths, angles and dihedrals improve the ratio of observations to the 
refined parameters. If multiple copies of the molecule are present in the asymmetric 
unit, non-crystallographic symmetry can be used to average equivalent molecules, 
increasing the signal to noise ratio.
Exray describes the difference between observed and calculated diffraction data:
E^y = £  [I Fobs(h)| - k  I Fcdc (h)| ]2h
This equation only incorporates information about the amplitudes of the observed 
reflections. Phase restraints can be added based on the difference between experimental 
phases and those calculated from the model:
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Exray — S  [I Fobs(h)l " ^  I Fcalc (h )l ] Wp S  f  [ $obs(h) “ <J>calc(h)]
h h
Where wp is the weight given to the phase restraint and/is a square-well function with a 
width equal to the arccosine of the Figure of merit [/w(h)] for each reflection.
Methods of refinement
There are two basic types of approach to optimisation; stochastic methods and 
deterministic methods. Deterministic methods such as Conjugate Gradient (CG) which 
identifies the nearest minimum in the target function by increasing the radius of 
convergence; and least squares (LSQ) -  the weighted sum of squares of the deviations 
between the observed and calculated quantities. Optimisation problems in protein 
crystallography generally suffer from there being multiple minima, which arise largely 
from the high dimensionality of the parameter space (at least three times the number of 
atoms in the molecule). Both LSQ and CG tend to have problems with the many local 
minima of the target function. LSQ assumes that the current phase is correct, that the 
atoms should move towards or away from a certain plane rather than an unknown plane. 
These methods are simply not capable of shifting the atomic co-ordinates enough to 
correct errors in the initial model. Maximum likelihood target functions avoid these 
assumptions (Brunger et a l9 1997). Simulated annealing is an optimisation technique 
particularly suited to overcoming local minima thus exploring a larger area of parameter 
space. Annealing is a physical process whereby a solid is heated to sufficient 
temperature such that it becomes a viscous liquid of randomly arranged particles. Slow 
cooling of the liquid phase causes the particles to arrange themselves in the lowest 
energy state. By formally defining the target E  as the potential energy of the system the 
annealing process can be simulated. Simulated annealing as a molecular dynamics
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refinement method, in combination with the optimisation techniques is the most 
commonly used protocol. The temperature of the system initially at 300°K is heated to 
5000°K before cooling. The simulated annealing temperature has no physical meaning 
and simply defines the likelihood of overcoming the barriers of the target function. The 
most commonly used programs for crystallographic refinement are CNS (BrUnger,
1998), X-PLOR (BrUnger et al.f 1992) and REFMAC as part of the CCP4 program suite 
(CCP4,1994). All three of these programs use minimisation and simulated annealing in 
combination. Uniquely, CNS uses a combined simulated annealing/maximum 
likelihood protocol for model refinement (Briinger et a l t 1998, Adams et al, 1997).
The use of a maximum likelihood protocol necessitates the computation of cross­
validated a  A values. The cross-validated a  A error estimates and the weight between 
X-ray diffraction target function and the geometric energy function are recalculated 
during the refinement procedure. Since the maximum likelihood function depends on a  
A error estimates recalculation is extremely important, so this step is performed after the 
initial energy minimisation and after molecular dynamics. The position (x,y,z) and 
thermal parameters (B -  factor) of each atom are then refined against the X-ray 
observations. It is here that the R-factor becomes important. The value of R indicates 
the agreement between calculated and observed intensities. Successive cycles of 
refinement followed by rebuilding of the model are necessary in order to produce a well 
refined structure with an R-factor of approximately 0.20, and an R-free in the region of 
0.25 -0.28. Other ways of assessing the model as refinement progresses include the 
RMS deviation of bond lengths and angles from ideal. Large errors within the structure 
are not usually corrected for by the previously mentioned refinement procedures. These 
errors are normally corrected by manual rebuilding of the model assisted by different 
types of electron density maps. Calculation of omit maps is performed to remove model
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bias from ambiguous areas of the model. Techniques such as bulk solvent correction are 
used to improve the signal to noise ratio of electron density maps for missing parts of 
the model.
The program ‘O’ is by far the most widely used model-building tool in crystallography 
(Jones et al, 1991). It provides a set of tools for manipulating the model and viewing 
electron density maps. The model can be rebuilt using a set of macros to rotate/move 
small parts of the model manually, insert, mutate or delete residues and assign side 
chain rotamers from a database. Local real space refinement can also be carried out 
during rebuilding in order to improve the model. The process of model building and 
refinement is an iterative process that continues until compliance is reached.
Structure analysis
Once the structure has been refined to a satisfactory Rconventionai and R ^e value, the 
overall architecture of the molecule is assessed. The Ramachandran plot (<p and y/ 
angles of the polypeptide backbone) allows the evaluation of the geometry of the 
structure. Programs such as PROCHECK (Laskowski et al.9 1993) provide this and 
various other assessments on geometry, bond length and temperature factors based on 
an analysis of 118 structures of resolution at least 2 .0 A  and an Rconventionai less than 20% . 
Close examination of the intra- and intermolecular contacts in the crystal and polar and 
non-polar interactions should also be performed. By superposition of the structure with 
known homologous structures, other crystal forms of the same structure, or 
native/mutant comparisons, functional regions can be assessed.
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Structure deposition
Once a structure has been completed the atomic co-ordinates, experimental details, 
sequence data, points of interest about the structure, references, contact information and 
the names of the authors are submitted to a central database. The Protein Data Bank 
(PDB) is the global repository for structural information for X-ray crystallographic, 
NMR and theoretical models (Bernstein et al, 1977). Deposition is usually carried out 
via a web interface such as Auto Dep. The PDB is an open access searchable database 
that provides unique research resources for the biomedical community.
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Overview of Superantigens
The focus of this research is the structural and functional features of superantigens 
(SAgs). SAgs fall into two broad categories; bacterial and viral. Bacterial superantigens 
are potent T cell stimulatory protein molecules produced by Staphylococcus aureus and 
Streptococcus pyogenes (Marrack and Kappler, 1990). Their function in the microbe 
appears primarily to debilitate the host sufficiently through their effects on cells of the 
immune system to permit the causation of disease (Kotzin et al., 1993). Their 
superantigenic activity can be attributed to their ability to bind to both MHC class II 
molecules and T cell receptors by forming a trimolecular complex (Marrack and 
Kappler, 1990). Unlike conventional antigens they are not processed internally by ■ 
antigen presenting cells (APC), and are thus not displayed as peptide antigen in the 
peptide-binding groove of the MHC class II molecule. Superantigens bind to APCs on 
the outside of MHC class II molecule and to T cells via the external face of the T cell 
receptor (TCR) Vp element (Figure 2.1). Each superantigen interacts with a specific Vp 
region of the TCR, stimulating a large fraction of T cells (for example, up to 10% of 
resting T cells) (White et al., 1989).
Staphylococcal enterotoxins (SEs) A, B, Cl-3, D, E, H; toxic shock syndrome toxin-1 
(TSST-1); the streptococcal pyrogenic exotoxins (Spes) A, C, H; streptococcal 
mitogenic exotoxin SME-Z2 and streptococcal superantigen (SSA) are the most well 
studied superantigens to date :for a recent review see Papageorgiou and Acharya (2000). 
Other pathogens, such as Mycoplasma arthritidis and Yersinia enterocolitica have also 
been shown to secrete superantigenic proteins, though they are yet to be fully 
characterised (Cole et al., 1996). Viral superantigens are implicated with infections 
caused by rabies virus, Epstein-Barr virus, human herpesvirus including HIV (Huber et
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al. , 1996, Huber, 1995). Throughout this work discussion will be focussed on bacterial 
superantigens.
T - C e l l
Figure 2.1: Schematic representation illustrating the differences between conventional peptide 
antigen presentation and superantigen presentation to MHC class II and TCRs: Left to Right- 
conventional antigen is processed by the antigen presenting cell and displayed as discrete peptide 
fragments within the peptide binding groove of MHC class II molecules. Interaction occurs 
between TCR and MHC class II molecule through two possible modes: a) superantigens bind to 
the solvent exposed face of the MHC class II molecule (a l)  via its generic site, forming a bridge 
between TCR (Vp) and MHC class II molecule; b) Interaction also occurs between TCR Va and 
MHC class II molecule involving the (3-chain ((31) where the superantigen binds to MHC class II 
molecule via a bridging zinc atom. In both cases the MHC class II associated antigenic peptide 
has been shown to influence T cell recognition of superantigen/MHC class II molecule complex.
Common Architecture
The superantigen family comprises proteins o f 22-29 kDa in size that are highly 






Figure 2.2: Ribbon diagrams of the known superantigen structures illustrates the 2 domain architecture of the family. 
SEB (centre), TSST-1, and SEH are shown with annotations. The blue spheres represent zinc atoms.
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Figure 2.3: Multiple sequence alignment of superantigens with known structure. Residues implicated in TCR recognition are shown in green, residues 
involved in MHC II binding are shown in red, and those residues that act as zinc ligands are shown in light blue. The secondary zinc site in SEA is 
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Based on amino acid sequence alignment o f streptococcal and staphylococcal 
superantigens (Figure 2.3) it is possible to divide them into three subfamilies- (a) SEA, 
SED, SEE, SEH and SEI; (b) SEB, SEC1-3, SpeAl-3, SSA and SEG and (c) SpeC, 
SpeJ, SpeG. TSST-1 has -28%  homology with other SEs and cannot be grouped with 











Figure 2.4: Dendrogram (un-rooted) of the members of the superantigen family.
Allignments created using the program ClustalX (Thompson et al., 1994).
Calculation o f an un-rooted tree including SpeH, SpeX, SMEZ, and SMEZ2 as shown 
in Figure 2.4 gives a slightly different grouping. SEG, SSA, SpeA, SEC2 and SEB form 
one family, SEA, SED, SEE, and SEH form a second family, SMEZ1, SMEZ2, SpeX, 
SpeG, and Spec a third family, and TSST-1 is grouped SpeH and SEI.
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Comparison of the three-dimensional structures of superantigens [see Papageorgiou and 
Acharya (2000) and references therein] reveals a conserved two-domain architecture 
(N- and C- terminal domains) and the presence of a long, solvent-accessible a-helix 
spanning the centre of the molecule (Figures 2.2 and 2.5). The N-terminal domain has 
considerable structural similarity to the oligosaccharide/ oligonucleotide-binding fold 
(OB-fold) found in other proteins of unrelated sequence such as staphylococcal nuclease 
and the AB5 toxins, and is characterised by the presence of hydrophobic residues in its 
solvent exposed regions. As its name implies, in other proteins the OB-fold is involved 
in DNA binding or carbohydrate recognition though no such activity has been attributed 
to superantigens so far. The C-terminal domain is composed of a four-stranded P-sheet 
capped by the central a-helix. Structurally, it is reminiscent of the p-grasp motif found 
in other proteins such as ubiquitin and 2Fe-2S ferredoxin. Other common features 
include a highly flexible disulphide loop (see Figure 2.5 ), present in the N-terminal 
domain of SEs and SpeA, but not in TSST-1 and SpeC. This flexible loop is implicated 
in the emetic properties of the SEs and indeed mutation of the residues that form this 
disulphide loop to alanine abolishes the emetic activity in SEC1 (Hovde et al., 1994). 
Moreover mutation of either one of the cysteine residues in SpeA also reduces its ability 
to stimulate certain populations of T cells significantly (Kline and Collins, 1997).
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Figure 2.5: Ribbon diagram of SEA as a representative superantigen highlighting the common 
structural features of the family.
Purification Procedures
Several procedures have been adopted to purify superantigens in their native forms 
(Avena and Bergdoll, 1967, Chu et al., 1966, Ende et a l ,  1983, Reynolds et al., 1988, 
Robem et al., 1975). Most o f them are multi-step procedures and are not always suitable 
for large scale toxin production. Brehm et al (1990) developed a single-step dye ligand 
chromatography assay for the purification o f SEA, SEB, SEC2, and TSST-1 using Red 
A gel. The procedure caters for both small- and large-scale preparations o f toxins from
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S. aureus with good yields. Many studies have favoured the use of recombinant toxins. 
These proteins can be produced as fusion proteins such as GST tagged (Proft et a l , 
1999; Sundberg and Jardetzky, 1999) or His-tagged toxins (Munson et a l, 1998) 
allowing a simple two-step cleavage and purification method. In all cases, whether 
native or recombinant, further purification by isoelectric focussing may be required to 
produce a single isoform. The exclusion of bioactive contaminants during toxin 
purification is esstential. For example, native SpeA, commercially available SpeA and 
recombinant SpeA preparations were all shown to be contaminated with DNase and an 
unknown protease. This contamination interferes with many immunological assays as 
DNase has been shown to independently induce cytokines (Fagin et a l, 1997). A 
balance must be achieved therefore, between ease of purification and the purity of the 
final sample.
Detection Methods
There are several reliable assays for the detection of bacterial superantigens; namely the 
micro-slide, double diffusion and ELISA based methods. Qualitative assays for 
bacterial superantigens are performed using the following technique (Schlievert, 1988). 
Briefly, an agar plate cultured with the test organism has hyperimmune antisera and 
purified superantigen added to separate wells punched 4 mm to each other from the 
growing organism. After 12 hours incubation at 37°C the plate was examined for the 
formation of a precipitation arc that forms between antibodies present in the anti-sera 
and the superantigen, both in its purified form and from the cultured organism, if 
present. Quantitative assays such as the double immunodiffusion allow an estimate of 
the amount of toxin present in an isolate by comparison to an assay performed on a 
control toxin of known concentration. The detection range of this method, 
approximately 4 pg/ml, can be extended 2- to 4- fold by drying and staining the slides
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(Schlievert, 1988). Several ELISA based methods for the detection of superantigens 
have been developed (Parsonnet et al., 1985, Sriskandan et al., 1996a, Sriskandan et 
al., 1996b) allowing multiple samples to be tested accurately and relatively quickly. 
Commercially available kits based on several of the above methods are available such 
as Ridascreen (R-Biopharm GmbH, Germany) and TECRA (International Bioproducts, 
Redmond, WA, USA) which are ELISA kits for the detection of SEs A to E. A reversed 
passive latex agglutination assay kit, SET-RPLA (Oxoid, Ontario, Canada) can also be 
used for the detection of SEA, B, C, D and E.
Binding to MHC class II Molecules
Structural analyses using X-ray crystallography have shown that MHC class II 
molecules possess two distinct superantigen binding sites [for details see Papageorgiou 
and Acharya ( 2000)]. The first, a low affinity binding site (referred to as the generic 
site) is located on the a-chain of the MHC class II molecule and the second, a high 
affinity (~100 times higher affinity than the generic site) zinc-dependent site is located 
on the (5-chain (Figure 2.1). The structures of SEB and TSST-1 in complex with HLA- 
DR1 via the low affinity site (Jardetzky et al., 1994), SpeC in complex with HLA-DR2 
(Li et a l, 2001) and SEH in complex with HLA-DR1 (Petersson et a l, 2001) via the 
high affinity site have yielded a great deal of information about the binding of S Ags to 
MHC class II molecules (Figure 2.6 A -  D). Each superantigen binds to different 
haplotypes of class II molecules to varying degrees. Whilst the majority of the 
superantigens including TSST-1 and SEB bind preferentially to HLA-DR alleles, 






Figure 2.6: Ribbon diagrams of the structures of SAgs complexed with MHC class II 
molecules. (A) SEB -  DR1 complex (Li et al., 1998). (B) TSST-1- DR1 complex (Kim et 
al., 1994).(C) SEH in complex with DR1 via its high affinity zinc binding site (Petersson et 
al., 2001). (D) A model of the bivalent SEA binding to DR1 (Tiedemarm et al., 1995). 
Superantigens in red, MHC II (3chain blue a  chain green, zinc ions are shown as blue 
spheres and the antigenic peptide is coloured yellow.
For both SEB and TSST-1 in complex with HLA-DR1, similar binding modes with the 
a-chain o f DR1 involving the solvent exposed, hydrophobic core at the N-terminal 
domain o f the toxin molecule were evident (Figures 2.6A, 2.6B, 2.7). Similar 
hydrophobic ridge regions (except SpeC, SpeH and SME-Z2) form the generic site and 
are implicated in class II binding. However, in the case o f TSST-1 additional contacts 
with the peptide antigen were also present (Kim et al., 1994). Indeed, truncating the C- 
terminal end o f the peptide dramatically effects TSST-1 binding to murine I-Ab (Wen et 
al., 1997).
In addition, several members o f the superantigen family (except SEB, TSST-1 and SSA) 
possess either one or two zinc binding sites (Papageorgiou and Acharya, 2000) (for
Superantigens: structure function and diversity
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details see Table 2.1, Figures 2.2,2.5,2.6). The presence of the zinc ion is important for 
the recognition of class II molecules. Mutational and structural analyses have identified 
a high affinity zinc binding site in SEA at the C-terminal domain with a Ad of 100 nM 
for DR1 recognition (Fraser et al., 1992). However, the zinc-independent generic site at 
the N-terminal domain has considerably lower affinity (Ad of 10 pM) for class II 
binding. If the two binding sites co-exist, SEA shows a Ad of 13 nM. Mutations of 
residues in either of these sites results in a toxin unable to induce cytokine expression in 
peripheral blood mononuclear cells (PBMC) (Abrahmsen et al., 1995). Thus in the case 
of SEA molecule, it possesses two distinct MHC class II binding sites which might 
enable the formation of the trimeric SEA-MHC-SEA complex as observed in solution 
experiments (Tiedemann et al., 1995) (Figures 2.6 D and 2.7). Similar arguments can be 
put forward for SEE as both SEA and SEE possess identical zinc ligands.
In the case of SEC and SpeA, the high affinity zinc-binding site observed in SEA is not 
present However, a new zinc binding site with somewhat lower affinity compared with 
the high affinity zinc binding described above (the estimated dissociation constant for 
the zinc ion in SEC2 is <1 pM) was identified at the N-terminal domain which also 
appears to be important for MHC class II binding (Figure 2.5) (Papageorgiou et al.,
1999). We shall refer to this site as the secondary zinc-binding site. In SED (Sundstrom 
et al., 1996) and SpeC (Roussel et a l, 1997), the situation is slightly different since this 
toxin can form zinc-dependent homodimers (in SED) and zinc-independent homodimers 
(in SpeC) and binds solely to the p-chain of MHC class II molecule by a zinc-mediated 
mechanism similar to that of SEA and could form either trimers or tetramers. A similar 
binding mechanism has been proposed for SEH which also lacks a generic MHC class 
H binding site (Hakansson et al., 2000) (Figures 2.6 and 2.7).
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Figure 2.7: Schematic diagram illustrating the multiple modes by which 
superantigens can interact with MHC class II molecules.
The recent structures o f SpeC in complex with HLA-DR2 (Li et al., 2001) and SEH in 
complex with HLA-DR1 (Petersson et al., 2001) via the high-affinity zinc-dependent 
site have shed more light on the interactions o f superantigens with MHC class II 
molecules (Figures 2.6C, and 2.7). The interaction between both superantigens and their 
MHC class II molecules is mediated by a bridging zinc ion, which tetrahedrally co­
ordinates three ligands from the SpeC (His 167, His 201 and Asp 203) and two from 
SEH (His 206, Asp 208 and a water molecule) with one from the MHC class II p 1 helix 
(His 81).
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There is also extensive contact between SpeC and the class II associated antigenic 
peptide (approximately one third of the contact surface area) and stabilisation of the 
SEH-MHC class II complex also occurs through interaction with the antigenic peptide. 
Both the SpeC and SEH complexes have similar interactions with the antigenic peptide 
despite the fact that the peptides in each structure are different. This indicates that 
although the peptide plays an important role in the complex interaction, 
superantigen/MHC binding is not entirely peptide specific as a majority of the 
interactions with the peptide is with its backbone atoms.
Zinc is also shown to play a role in the binding of SME-Z2, SpeG, and SpeH to MHC 
class II molecules, as the binding of all three of these superantigens to LG-2 cells is 
significantly reduced by the addition of EDTA (Proft et al., 1999). The proposed zinc- 
binding site in each of these superantigens is shown to be closest to that of SEA and 
SpeC, both of which have geometrically and spatially equivalent site (Roussel et a l,
1997). As the presence of the zinc binding ligands suggest, all three of these 
superantigens bind to MHC class II molecules in a zinc dependent fashion.
There appears to be a great deal of diversity in the mechanism by which superantigens 
can mediate with MHC class II molecules, either through zinc-mediated interaction or 
via the generic site or involving both site/s giving each superantigen a unique array of 
possible interactions through which it can exploit the immune system.
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Table 2.1: Comparison of the high affinity (zinc-dependent), and low affinity (generic) MHC class 






S E A yes High affinity site S I ,
HI 87, H225, D227. 
SEC2-like site D86, HI 14, 
E 3 9 (m012), H 2O
(Fraser et al., 1 9 9 2 )  
(Sundstrom et al., 
1 9 9 6 )
S E B yes No (Papageorgiou et al., 
1 9 9 8 )
S E C 2 yes H I  1 8 , H 1 2 2 ,  D 8 3 ,
D9(Symmetry related molecule)
(Papageorgiou et al., 
1 9 9 5 )
S E D yes H 2 1 8 (moll) D 1 8 2 ( m0l2), 
H 220(m ol2), D 2 2 2 ( mo12)* . 
SEC-like site H8, El 2 ,  
H 109(m ol2), K 113(m ol2).
(Sundstrom et al., 
1 9 9 6 )
SEE yes H I  8 7 ,  H 2 2 5 ,  D 2 2 7 (Fraser et al., 1992)
S E G No (Munson et al., 
1 9 9 8 )
S E H No generic 
site
H 2 0 6 ,  D 2 0 8 (Hakansson et a l, 
2 0 0 0 )
S E I No (Munson et al., 
1 9 9 8 )
T S S T -1 yes No (Papageorgiou et al., 
1 9 9 6 )
Streptococcal
SpeA yes G 3 3 , D 7 7 ,  H I  0 6 ,  H I  1 0 . (Papageorgiou et al., 
1 9 9 9 )
(Earhart et a l, 2000)
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(Baker, 2001)
SpeC No generic HI 67, H201, D203. (Roussel et a l, 1997)
site (Li e ta l, 2001)
SpeG No generic #H167, H202, D204. (Proft e ta l, 1999)
site
SpeH No generic *H198, D200, D160 (Proft et a l, 1999)
site
SME-Z No generic *H202, D204, HI 62 (Proft et al., 1999)
site (Proft et a l, 2000)
SME-Z2 No generic *H202, D204, HI 62 (Proft e ta l, 1999)
site (Proft et a l, 2000)
SMEZ3/SPEX No generic *H202, D204, H162 (Gerlach et a l, 2000)
site
SSA yes No (Sundberg
andJardetzky, 1999)
* And vice-versa (moll -mol2) for second zinc atom 
# Proposed residues based on sequence alignment
Binding to TCR-Vp Regions
The characterisation of superantigen-TCR binding region reveals many similarities and 
differences. This is reflected by the fact that they bind to TCR through a somewhat 
similar mechanism, yet have different Vp specificities. The binding is mediated by 
interactions between the side-chains of the superantigen and the Vp backbone atoms in a 
manner similar to that of MHC-peptide and antigen-antibody complexes (Figure 2.8)
(Li et al., 1998). The TCR binding site has been shown to involve a shallow cavity 
between the two domains of the molecule. For SEB this cavity is formed by residues 
22-33 (mostly a2 helix), 55-61 (P2-p3 loop), 87-92 (P4 strand and p4-p5 loop), 112 (p5 
strand) and 210-214 (a5 helix) (Swaminathan et a l, 1992) (Figures 2.2,2.5 and 2.7).
48
Chapter 2 Superantigens: structure function and diversity
Analogous sites for SEC and SEA have also been proposed. The crystal structures of 
SEC2 and SEC3 in complex with TCR Vp chain by Fields et al (1996) and the complex 
between a T cell receptor beta chain and SEB have further elucidated the detailed 
interactions of superantigens with a TCR molecule (Figure 2.7). The main interactions 
are shown to be between the side-chain atoms of the superantigen and complementarity 
determining regions one and two (CDRs 1 and 2), and hypervariable region 4 (HV4) of 
the Vp chain. Comparison of this TCR binding site (from SEC2/3) with the 
corresponding regions of SEA and SEB identifies an invariant asparagine residue (Asn 
23 in SEB/SECs; Asn 25 in SEA), as being crucial for direct interactions with the TCR. 
Mutation of this residue in SEB results in the loss of T cell stimulation (Kappler et al.,
1992). This residue is solvent exposed in SEA, SEB and SEC, and is thought to be 
involved in similar interactions with the TCR in all the SEs. Leder et al (1998) 
evaluated the functional contribution of individual SEC3 residues to the stabilisation of 
the SEC3/Vp complex by alanine scanning mutagenesis of all the residues of SEC3 
shown to be in contact with the P-chain in the crystal structure (Fields et al., 1996). It 
was found that the mutations that had the most effect on binding to the TCR P-chain 
were Asn 23, Tyr 90 and Gin 210. Tyr 90 and Gin 210 are conserved among SEC1-3, 
SEB, SpeA, and SSA has analogous residues Asn 49, Tyr 116 and Gin 223 
(Swaminathan et al., 1992).
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Figure 2.8: (Left to right)The structures of SEB (Li et al., 1998) and SEC2/3 (Fields et al., 
1996) in complex with T cell receptors.
Modelling experiments with the TCR-SEB complex and a peptide/MHC class II 
complex indicate that Va o f the TCR interacts with the MHC beta chain in the TCR- 
S AG-MHC complex (Li et al., 1998). The extent o f the interaction is shown to be 
variable and is largely determined by the geometry o f Va/Vp domain association. This 
variability could account for the preferential expression o f certain Va regions among T 
cells reactive with SEB.
As mentioned earlier, the variance between superantigens with regard to TCR affinity 
and specificity can be accounted for by several residues unique to each particular 
superantigen as well as the any topological influence that each o f these might have. For 
example, the residue Tyr 26 o f SEC2 confers specificity between SEC1 and SEC2 via 
its interaction with Gly 53 from the Vp chain (Deringer et al., 1996). This residue is not 
conserved in SEA or SEB. Val 91 o f SEC2 is also implicated in TCR binding. This 
residue is not conserved in SEA (Tyr 94) or SEB (Tyr 91) either (Tiedemann et al., 
1995) and it is thought that the replacement o f Val 91 by a tyrosine residue in SEB may
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be responsible for its reduced affinity for the Vp8.2 chain (Fields et a l , 1996). Ser 206, 
Asn 207 and Thr 21 have been identified as the probable specificity defining residues in 
SEA (Swaminathan et a l , 1992). This is highlighted by the exchange of residues 206 
and 207 in SEA for the homologous residues in SEE causing the profile of Vp elements 
on the responding T cells to change to that of SEE (Hudson et a l, 1993). Ser 206 and 
Asn 207 in SEA correspond to Gin 210 and Ser 211 respectively in both SEB and 
SEC2. The greatest energetic contribution to the stability of the Vp-superantigen 
complex is made by those residues that define its specificity for particular Vp elements 
(Li e ta l, 1998).
The TCR binding site of TSST-1 is located in the C-terminal domain on the long a2 
helix and between the p7-p8 and a2-p9 loops as part of the a  1 helix (Figure 2.2). In 
this regard, it is unique from the SEs (Acharya et a l, 1994). Mitogenicity is lost either 
partially or completely, by mutation of residues in the region 115-144. Specifically, 
residues Tyr 115, Glu 132, His 135, lie 140, His 141, and Tyr 144 were shown to be of 
major importance for TSST-1 binding to TCR (Acharya et a l, 1994, Deresiewicz et a l, 
1994). Mutation of these residues produce substantially less mitogenic toxins, yet they 
can still be recognised by a specific antibody (Deresiewicz et a l, 1994). The TCR 
binding site of SpeC is as yet not fully characterised. As it is structurally very similar to 
TSST-1 it is possible that SpeC shares similar TCR binding characteristics.
In summary, the interactions between superantigens and TCR share a common core of 
residues with specificity for particular Vp elements being supplied by further residues 
unique to each toxin, giving rise to a characteristic Vp repertoire.
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Signal Transduction Pathways of Superantigens
The primary targets of superantigens are the CD4+ T cells (Bavari and Ulrich, 1995),
activation of which results in T helper type 1 (Thl) cytokine release with no apparent 
Th2,response (Krakauer, 1995). The consequences of a dominant Thl response include 
suppression of antibody expression and reduced clearance of the invading microbe. A 
model of superantigen signal transduction can be constructed based on the TCR- 
oligomerisation model of T cell activation. This model proposes that binding of a ligand 
to TCR induces clustering of the TCRs on the cell surface, facilitating the recruitment of 
the intracellular components required for signal transduction (Germain, 1997). It would 
seem that superantigens have evolved to mimic peptide antigens with respect to receptor 
clustering (Woodland et a l, 1997), either through direct clustering events, or by the 
binding of superantigen homodimers to multiple MHC class II molecules which would 
in turn promote T cell clustering (Tiedemann et al., 1995). Superantigens that act as 
monomers and that possess only a single MHC class II binding site appear to rely on the 
interactions of the TCR Va and MHC class 11-01 which increases the stability of the 
ternary complex to within the range seen for conventional antigen. A stable 
MHC/superantigen/TCR complex with an extended half-life would therefore facilitate 
receptor clustering.
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The consequences of superantigen exposure
Figure 2.9 shows a model for superantigen induced shock. The massive T cell 
proliferation induced by superantigens results in the release o f high levels o f a variety o f  
cytokines both from macrophages and from T cells. These include IL-1 and TNF-a 
from macrophages and TNF-P, IL-2 and IFN-y from T cells (Herman et a l , 1991). All 
these cytokines have deleterious effects on the host when present in high concentrations, 
including the production o f hypotension through capillary leak (Figure 2.9) and are 
involved in the aetiology o f toxic shock, food poisoning and scarlet fever in man and 
animals.
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Figure 2.9: The consequences of superantigen exposure. The culminative effects of 
superantigen on the immune system leads to hypertension and systemic shock as a 
result of capillary leak. Prolonged exposure to superantigen can lead to 
immunosuppression and tolerance.
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In vivo experiments with SEB show that most cytokine expression is transient and 
occurs within the first twelve hours whereas signals involved in proliferation such as 
DNA synthesis and IL-2 receptor expression are not apparent until over twenty four 
hours from SEB exposure (Picker et a l, 1995). Once cells have undergone DNA 
synthesis they are then capable of re-expressing cytokines prior to a second round of 
proliferation (Mehta and Maino, 1997).
Roles of Superantigens in Disease 
Toxic Shock Syndrome
Toxic shock syndrome (TSS) is a serious, life threatening disease resulting from an 
infection of a susceptible host by Staphylococci or Streptococci expressing 
superantigens in vivo. TSST-1 is the key virulence factor responsible for TSS, inducing 
most TSS symptoms in animals. TSST-1 is responsible for nearly all menstrual TSS 
cases and approximately 60% of non-menstrual Staphylococcal TSS. The remainder of 
the cases can be attributed primarily to SEB production, and to a lesser extent SEC and 
SEA (Bernal et a l, 1999). Streptococcal TSS can be attributed mainly to SpeA (Hauser, 
1991).
The pathogenesis of the disease is yet to be fully elucidated, although it is clear that 
toxic shock is in part a result of the superantigenic nature of the toxins. The high levels 
of cytokines released due to massive T cell proliferation affect the cardiovascular 
system by causing extensive epithelial damage, capillary leak and decrease in peripheral 
vascular resistance resulting in shock as well as reducing kidney and liver function. 
TSST-1 is unique among the superantigens as it is capable of crossing the epithelial 
barriers and subsequently inducing toxicity (Schlievert et a l, 2000). This activity is
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thought to be due to the unique structural features of TSST-1 that are not present in 
other members of the superantigen family. The mechanism by which TSST-1 crosses 
the epithelial barrier could include either passive diffusion, or more likely, the use of 
cellular receptors (Schlievert et a l , 2000). The most pronounced structural differences 
between TSST-1 and the other superantigens are the lack of an a-helix in the C-terminal 
domain, the long N-terminal extension and the disulphide loop. TSST-1 also has unique 
patches of hydrophobic and neutral residues on the front and rear of the P-barrel at the 
N-terminal domain. Many of these features could combine to produce a receptor 
specific binding site in order for TSST-1 to traverse epithelial cells and allow systemic 
shock.
Superantigens and Food Poisoning
Staphylococcal food poisoning (SFP) is the leading cause of microbial food-bome illness 
worldwide. Food sources that are contaminated most often include foods that are high in 
protein, salt and sugar. Abdominal pain, nausea, vomiting, and diarrhoea are commonly 
seen within two to six hours of ingestion of contaminated food, the absence of fever 
suggests that toxemia is at most, minimal. Little is known about how superantigen 
structure relates with emetic and diarrhoea activity. It has been suggested that the 
symptoms of food poisoning are a result of the high levels of cytokines released 
following superantigen induced T cell proliferation. Indeed, cancer patients receiving IL- 
2 therapy often experience side effects that mimic SFP. More recent work indicates that 
the emetic properties of these toxins are not completely correlated with their 
superantigenicity (Harris and Betley, 1995). Work by Hoffinan et al (1996) indicated that 
the carboxy-terminal histidine at position 225 of SEA was important for both the 
superantigenic and emetic activity, yet histidine 61 appears to be important only for 
emetic activity. Harris and Betley. (1995) have identified further areas in the N-terminal
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region of SEA that are important for both emetic and superantigenic function. A different 
study on the carboxymethylation of His residues in SEB abrogates emetic activity but 
still induces peripheral blood cell proliferation in monkeys (Alber et al., 1990) consistent 
with the hypothesis that the two activities are separable in staphylococcal enterotoxins. 
This is supported by investigations using peptides encompassing distinct regions of 
SEC1. Intravenous administration of one such peptide, a 22kDa C-terminal fragment, 
was found to induce diarrhoea but not emesis in primates (Spero et al.9 1978). One of the 
main regions of these toxins thought to be responsible for emesis is the disulphide bond 
and loop (Hovde et al., 1994). They reported that the disulphide bond itself is not an 
absolute requirement for emetic activity. However, conformation within or adjacent to 
the loop is important for emesis. Thus, it is evident that further work is required in order 
to assess the contribution of certain amino acids to the various biological activities 
shown by superantigens in the context of the diseases they cause.
Superantigens and Autoimmunity
Due to their mode of action superantigens have been identified as a possible candidate 
for one of the causative agents of autoimmune disease (Kotzin et al.9 1993, Friedman et 
a l , 1993). Since autoreactive T and B cells can easily be isolated from the peripheral 
blood of healthy individuals (Hohlfeld et a l9 1984, Wucherpfennig et al.91991), 
superantigens could stimulate auto-reactive T cells both locally and systemically, since 
they do not discriminate between autoimmune and normal lymphocytes (Brocke et a l9 
1998). Thus the delicate balance of tolerance could be broken. Although superantigens 
are yet to be directly implicated in human autoimmune disease, there is growing 
evidence to suggest their involvement For example, SED and SED-reactive T cell lines 
have been shown to stimulate auto-antibody production by B cells in vitro (Renno and
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Acha-Orbea, 1996). It has been shown that Staphylococcus aureus strain AB-1 is 
responsible for the spontaneous outbreak of staphylococcal arthritis in a colony of rats 
(Bremell et a l , 1994). When this strain was isolated from a swollen joint and injected 
intravenously into healthy rats, erosive, persistent arthritis developed in a majority of the 
rats. The arthritic lesions were characterised by the infiltration of T cells into the 
synovium. These T cells were later shown to be activated by a superantigen present in 
the infectious pathogen (Bremell and Tarkowski, 1995).
In the absence of infection, injection of low doses of SEA or SEB induces relapsing 
paralysis in Experimental Autoimmune Encephalomyelitis (EAE), the animal model of 
multiple schlerosis (Brocke et a l, 1 9 9 3 ) .  Further studies have shown that SEB can 
induce MBP-specific T cells expressing different V p to respond to myelin-antigens and 
mediate this relapsing paralysis (Gaur et a l, 1 9 9 3 ) .  Autoimmune conditions such as 
arthritis, diabetes and multiple schlerosis are characterised by heterogeneous T cell 
infiltrates during active bouts of the disease. This implies that a broad spectrum of 
superantigens could cause this exacerbation (Soos et a l, 1 9 9 7 ) .  Type I diabetes is 
associated with a retroviral superantigen which is thought to activate and expand T cells 
carrying the TCR V p 7  element which in turn has been implicated in the pathogenesis of 
insulin dependent diabetes mellitus (Conrad et a l, 1 9 9 7 ) .  Recently, the first case of type 
I diabetes associated with a bacterial superantigen mediated disease was reported 
(Couper et a l, 2000). However, it still remains unclear whether superantigens are the 
initial trigger of autoimmune disease; as environmental factors that can change a 
controllable illness into one that becomes relentless for susceptible individuals.
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In vivo Models
The mouse model for toxic shock firstly requires the administration of D-galactosamine 
to sensitise the mice two hours prior to injection of superantigen (Miethke et al., 1993a; 
Miethke et a l , 1993b). D-galactosamine destroys liver function and without its prior 
administration milligram quantities of toxin can be given to mice without inducing 
hypotension or shock. The model therefore, is not ideal, though it provides a starting 
point for experiments which can be expanded with other animal models. A rabbit model 
with most of the symptoms characteristic of human toxic shock syndrome (TSS) 
excluding rash and desquamation can be induced by injection of TSST-1 and endotoxin 
(Schlievert, 1982). Rabbits are first given a sublethal dose of TSST-1 as it is important to 
pre-condition the animals because TSST-1 is lethal to unconditioned animals. Four hours 
after the initial dose endotoxin is administered and the disease monitored by following 
the onset of TSST-1 induced fever by rectal thermometers and checking for signs of 
diarrhoea, hypothermia and awkward breathing. High doses of exotoxin can cause death 
within 3 hours. It is important to note that the symptoms observed in this model are not 
typical of endotoxin shock, but rather, are greatly accelerated in timescale (Bohach and 
Schlievert, 1988). A variation on this rabbit model was devised using a subcutaneous 
infusion pump to deliver a constant toxin dose at 150 jig over seven day period 
(Parsonnet et al., 1987). The highly reproducible nature of this model makes it ideal for 
studying the pathogenesis of TSS.
The monkey feeding test for Staphylococcal enterotoxins allows the potency of a 
particular sample to induce emesis and other symptoms of superantigen induced food 
poisoning to be assessed (Bergdoll, 1988). This model has been used both to test drugs 
designed to inhibit emesis and to determine the efficacy of vaccines designed to prevent 
illness in humans (Bergdoll, 1966).
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In vitro Models
TSST-1 pre-treated rat renal tubular epithelial cells (RTC) are sensitive to endotoxin 
induced necrosis at concentrations of less than lng/ml (Keane et a l, 1986). Briefly, RTC 
are incubated with non-toxic levels of TSST-1 for 20 minutes, washed, and then exposed 
to endotoxin. Cytotoxicity is assessed by either trypan blue staining or by using 
chemiluminescence to detect reactive oxygen species generated by those cells destroyed 
by endotoxin.
Direct assessment of complex formation, T cell stimulation and cytokine production can 
be assessed by using a T cell stimulation assay. Superantigen is incubated with antigen 
presenting cells and T cells (Leder et a l , 1998) and stimulation can be assessed by either 
incorporation of [3H] thymidine into DNA and counting on a scintillation counter, which 
measures secreted cytokine levels, or by fluorescence-activated cell sorting (FACS). 
PBMC (peripheral blood mononuclear cells) assays measure the superantigen induced 
proliferation directly without the need for antigen presenting cells to be present (Braun et 
a l , 1993) and stimulation can be assessed as with T cell assays.
TCR Vp analysis can be performed using the reverse dot-blot procedure (Hudson et al.,
1993). Total TCR Vp mRNA enrichment in human peripheral blood T cell cultures can 
be determined by a novel single-tube amplification technique using a redundant Vp- 
specific primer. Peripheral blood lymphocytes (PBL) are incubated with toxin for three 
days. TCR Vp-chain mRNA is then reverse transcribed using a set of primers specific for 
the conserved region in all Vp-chain genes. A radio-labelled Vp probe is then reverse 
blotted onto filters containing the individual Vp-chain genes. Relative changes in Vp- 
chain mRNA levels from superantigen stimulated PBL are then compared to mRNA 
levels in unactivated PBL.
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Superantigens- Vaccines and Therapeutic Potential
Historical evidence suggested that treatment with superantigens might be of potential 
therapeutic value for cancer patients. Over one hundred years ago William B. Coley 
administered heat killed bacterial cultures to cancer patients (Crossley, 1997). Many of 
the patients who had been injected with bacteria experienced a dramatic regression in 
their tumours and several experienced apparent cure. It is likely that these effects can be 
attributed to the immunostimulatory properties of superantigens in the injected bacterial 
preparation. Further evidence for the involvement of supeantigens in these early 
experiments was provided by the attempted immunoadsorption of tumour-blocking 
antibodies by passing the patients’ plasma over a protein A column. It was observed at 
the time, that treatment with this preparation was accompanied by all the symptoms of 
superantigen induced shock in the patient. It was later discovered that the columns were 
heavily contaminated with SEA and/or SEB. Protein A effectively binds several 
subclasses of immunoglobulins, but in contrast to SEs it has no immunoactivating 
properties compatible with the side effects observed in the patients. When protein A was 
produced recombinantly in E.coli., no toxic or therapeutic effects were observed. This 
suggestion of a therapeutic window where tolerable systemic immune activation can 
result in tumour regression has lead to recent attempts to specifically target superantigens 
towards tumours. The production of fusion proteins from tumour specific mAbs linked to 
superantigens represent the modem equivalent of these historic examples.
A majority of the recent work in this field has focused on the use of SEA fused to a 
tumour-reactive monoclonal antibody (Hansson et a l, 1997). The therapy works by 
targeting the superantigen directly towards the tumour; inducing infiltrating 
lymphocytes, the local release of tumour suppressive cytokines and the induction of 
apoptosis in tumour cells (Litton et a l, 1996, Dohlsten et a l, 1995a; Dohlsten et a l,
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1995b). A limitation to this approach is the accumulation of Fab-SEA fusion proteins in 
normal healthy tissues expressing MHC class II molecule. This causes immune 
activation and dose limiting toxicity (Hansson et a l, 1997, Dohlsten et a l, 1998). 
Mutation of residues in the high affinity MHC class II binding site reduces the systemic 
toxicity of the fusion protein whilst retaining potent anti-tumour activity (Hansson et a l,
1997). Similarly, several cell-based vaccines for the stimulation of immunity to 
metastasic cancers also employ superantigens in order to boost the immune response 
towards the tumour (Ostrand-Rosenberg et a l, 1999). Third generation vaccines 
consisting of tumour cells transfected with MHC class II, CD80, and SEB genes are very 
effective agents for the treatment of mice with established metastasic disease.
The available data for the superantigens highlights their involvement in many diseases 
through one common mechanism. The production of a vaccine against bacterial 
superantigens could therefore lead to the abolition of such diseases. At present especially 
with the number of reported cases of Multi-resistant Staphylococcus aureus (MRS A) on 
the rise, the need for a broad-spectrum vaccine or prophylactic effective against all 
structurally related bacterial superantigens is of paramount importance. Studies with 
SEA show that the MHC class II binding regions of superantigens represent the best 
target for site directed mutagenesis in order to produce a vaccine (Bavari et a l, 1996). In 
contrast, the TCR binding mechanisms of superantigens are not conserved (Ulrich et a l,
1998) and mutating a key amino acid residue in these sites may cause the acquisition of a 
new TCR Vp profile (Kappler et a l, 1992). As MHC class II binding residues are 
conserved reasonably well amongst the superantigens this seems like a more sensible 
area to start in order to produce an effective vaccine (Bavari et al. , 1996, Ulrich et a l ,
1998). Ulrich et al ( 1998) developed several vaccines based on conserved regions of 
SEA and SEB. These regions included residues in the hydrophobic pocket (Tyr 89-Ala,
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Thr 115-Ala, Glu 67-Gln) and residues in the hydrophobic binding loop (Gin 43-Pro, Phe 
44-Pro, Leu 45-Arg). Immunisation with these vaccines was found to protect mice and 
rhesus monkeys from lethal toxic shock. The antibodies produced against these vaccines 
also recognised and neutralised distantly related superantigens (Ulrich et a l, 1998).
Other strategies for attenuating superantigen action include low molecular weight 
peptides that can interfere with the binding of superantigen via the peptide binding 
groove.
Recently, Arad et al ( 2000) reported the identification of a dodecapeptide that prevents 
superantigen induced TSS in a mouse model. The peptide consisted of a highly 
conserved 12 residue stretch spanning residues 150 to 161 of SEB (P7 - strand - 08 - 
strand - a-4-helix). The peptide represents a region of no known function and is located 
outside of the known binding domains for both MHC class II molecules and TCR. 
Protected mice that survive subsequent lethal challenge with both staphylococcal and 
streptococcal superantigens rapidly develop protective antibodies against serologically 
distinct superantigens. The peptide was also shown to be effective at rescuing mice 
undergoing toxic shock. Similar work by Visvanathan et al (2001) using a peptide 
encompassing the same conserved region of superantigen structure plus a further thirteen 
residues (residues 150-174) gave further insight into how these peptide work. This 
peptide was able to protect against lethal shock in a rabbit model and block up to 90% of 
superantigen induced proliferation. Binding experiments indicated that the peptide binds 
tightly to MHC class II molecule preventing the association of superantigen. Antibodies 
raised against this peptide were also able to block the proliferative effects of 
superantigens. The broad specificity of these peptides makes them an ideal 
vaccine/therapy for superantigen-mediated diseases. However a clear mechanism on how 
these peptide/s function is yet to be elucidated.
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Another approach towards the inhibition of T cell response by superantigens is the use of 
bispecific receptor mimics. The strategy for the design of such molecules is to 
incorporate structural elements of the receptors required for binding of the toxin and not 
as a host of the natural ligand. As a result, only toxin binding is inhibited whilst the 
presentation of peptide antigen allowing a normal immune response is free to occur. 
Lehnert et al (2001) recently reported such a molecule from regions of DRa and TCR Vp 
joined together by a linker peptide that allows the two halves of the molecule to be held 
in correct orientations for binding of SEB. The receptor mimic inhibited SEB binding, 
blocked IL-2 release and stopped T cell proliferation. The dissociation constants for SEB 
binding to MHC class II-TCR complex and SEB-receptor mimic were very similar 
(Redpath et al., 1999) indicating that the amount required for competitive inhibition 
would also be in the nano-molar range. By extending this strategy, production of 
bispecific receptor mimics against other superantigens should be relatively straight 
forward and appears to have considerable promise.
Aims
The aim of this work is to further characterise the functional regions of bacterial 
superantigens that govern their specificity and potency.
By using a combination of mutagenesis and X-ray crystallography, the structural and 
functional contributions of individual amino acids will be assessed and their contribution 
to the activity of the toxin examined. In particular, the use of a zinc ion as a high affinity 
MHC class II binding site and the contribution that individual amino acids make to the 
TCR binding mechanisms of superantigens will be examined.
Ultimately, it is hoped that this work will support the previous studies suggesting that
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superantigens can interact with MHC class II and TCR in a subtle variety of ways, 
characteristic for each toxin. Further to this, toxins may be capable of employing 
multiple modes of interaction in order to elicit the required immune response.
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Introduction
In recent years there has been a resurgence of severe invasive streptococcal diseases. 
These include streptococcal toxic shock syndrome (STSS) associated with the 
production of streptococcal pyrogenic exotoxins (Spes), notably SpeA (Musser et al., 
1991), which can be isolated from a majority of patients suffering from the condition. 
SpeAl (Mr 25,787) is a member of the staphylococcal and streptococcal superantigen 
family. All of the toxins in the family induce fever, enhance susceptibility to lethal 
endotoxin shock, and stimulate T cells as superantigens. The correlation between STSS 
and SpeA producing strains of S.pyogenes is not surprising as the symptoms of toxic 
shock are characteristic of a superantigen mediated disease. In addition, Spes are 
cardiotoxic and have been postulated to be involved in diseases such as scarlet fever and 
erysipelas, as well as STSS and the early events leading to rheumatic fever and guttate 
psoriasis (Hauser et a l, 1995). Mutagenesis studies have begun to characterise the 
relationship between the different pyrogenic toxins and functional activity. A better 
understanding of such mechanisms will further our understanding of how microbes have 
evolved to interact with, and alter the human immune system and provide suggestions 
for novel therapeutics.
The crystal structure of SpeAl at 2.6 A resolution (Papageorgiou et a l, 1999) revealed 
that the toxin is considerably similar to that of other prototype superantigens (Figure 
3.1). Functional regions were characterised by structure based sequence alignment in 
combination with previous details of superantigen functional regions (Papageorgiou and 
Acharya, 2000). SpeAl was proposed to have a generic MHC class II binding site 
similar, but not identical to SEB.
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Figure 3.1: The crystal structure of native SpeAl; the arrangement of the four molecules in 
the crystallographic asymmetric unit. Each molecule is labelled.
Its TCR binding site was shown to have a common core like that o f SEC2, with 
variation in several other residues that produce its unique TCR Vp specificity. The 
structure also revealed a putative zinc binding site similar to that o f SEC2 
(Papageorgiou and Acharya, 2000), although no zinc ion was found to be present in this 
region. As a result, this subsequent study was performed in order to identify if  SpeAl
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did indeed possess a zinc binding site.The presence of a zinc site is SpeAl would 
indicate a second, high affinity MHC class II binding site in the toxin which combined 
with a generic MHC class II binding site could permit SpeAl multiple modes of action. 
To further support this a model of SpeAl in complex with HLA-DR1 was constructed 
and a series of mutants of the proposed zinc ligands were examined to determine the 
effect of zinc on the structure and function of the toxin.
Materials and methods
Purified SpeAl was supplied by Professor Carleen Collins, University of Miami 
Medical School, Miami, FL, USA. Recombinant SpeAl with an N-terminal His tag was 
expressed in E. coli BL21 (DE3) (Novagen), and purified by immobilised metal ion 
affinity chromatography as described previously by Papageorgiou et al (1999). 
Purification was carried out at pH 5.7 in order to inhibit dimer formation of the toxin. 
The eluted fusion protein was then cleaved with thrombin and tag and toxin were 
separated by dialysis against Phosphate buffered saline (PBS). Thrombin was removed 
from the preparation by chromatography overp-amino benziamidine agarose (Sigma 
Chemicals, St Louis, MO) and dialysed against PBS, 0.14M NaCl, 2.7mM KC1,5.4mM 
Na2HP04 and 1.8mM KH2PO4 before being concentrated with Centricon-10 filter units 
(Amicon).
Crystals were grown at 16°C using the hanging drop vapour diffusion method. Small, 
irregular crystals were produced in 16-19% PEG 3350,0.1 M sodium cacodylate buffer 
(pH 6.5) and 16% isopropanol. These crystals were then used for microseeding of 
hanging drops equilibrated against a reservoir solution containing 17% PEG 8000,
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0.2 M ammonium sulphate and 0.1 M sodium cacodylate buffer (pH 6.5). Crystals 
grown under these conditions were soaked in 2.5 mM zinc chloride (final concentration) 
12 hours prior to data collection.
Figure 3.2: A crystal of SpeA
Data collection and refinement
X-ray diffraction data to 2.8A were collected at 100°K using the crystallisation buffer 
containing 15% glycerol as a cryoprotectant at EMBL (c/o DESY), on beamline X I 1 
equipped with a MAR345 image plate. Forty-four images were collected in dose mode 
(480-560 sec/image), with an oscillation range o f  2° per image. A second data set was 
collected at MAX II, Max Lab to 2.9A resolution using a MAR345 image plate. The 
exposure time was 480 sec/image and the oscillation range was 1.0°. Data processing, 
scaling and merging was performed using the HKL program suite. (Otwinowski and 
Minor, 1997). Problems with differences in unit cell volumes between the two datasets 
due to cryogenic temperatures became apparent during data processing. This problem
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was overcome by the following scaling and merging protocol; Initially the two data-sets 
were scaled to produce .x files and merged to produce a .sea file. This .sea file was then 
merged back against the first dataset .x files in order to increase the bias towards the 
unit cell dimensions seen in the first set and to reduce the Rmerge- The final Rmerge was
10.8 % with an overall completeness of 95.8% (Table 3.1). Phases were determined 
using the structure of native SpeAl (Papageorgiou et a l, 1999) as a starting model. The 
initial model was subject to rigid body refinement. Calculation of a (I F0I - 1 F j ) electron 
density map revealed extra density at the predicted zinc binding site of the toxin for all 
four molecules in the asymmetric unit. The structure was refined by simulated annealing 
using tight non-crystallographic symmetry (NCS) restraints and the maximum 
likelihood target as implemented in the program CNS (Briinger et al., 1998). R&ec and 
Rciyst were used to follow the progress of refinement (Briinger et al., 1992). At the final 
stages of refinement grouped B-factor refinement and release of the NCS restraints was 
performed. SigmaA-weighted electron density maps (I F j - 1 Fj ) and (2| F j - 1 F j ) were 
calculated after each cycle of refinement and visualised using the program ‘O’ (Jones et 
al., 1991). Water molecules were added to the model towards the end of refinement 
with the aid of difference maps and the program water jpick in CNS (Briinger et a l .,
1998). The final model has a crystallographic Rfactor (Rciyst) of 22.5% for all data from 
40 to 2.8A resolution, and an R^e of 27.7% for 5% of the data omitted (Table 3.1).
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Figure 3.3: A sample diffraction image from a SpeAl with zinc data set.
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Molecular modelling of SpeAl in complex with MHC class II 
via its zinc site.
Molecule one of SpeAl was docked onto MHC class II in close proximity to His 81 of 
HLA-DR1 via its zinc site. Following energy minimisation using the program CNS 
(Briinger et al., 1998) the complex was examined visually for further interactions and 
clashes between the two structures.
Results and discussion 
Quality of the structure
The crystallographic data processing and refinement statistics are shown in Table 3.1. 
The final model consists of four molecules in the asymmetric unit containing 7,031 non­
hydrogen protein atoms, four zinc ions, and 143 water molecules. The root mean 
squares (r.m.s) deviation between the zinc-bound structure and the native structure is 
0.33 A (moll), 0.35 A (mol2), 0.30 A (mol3), and 0.38 A (mol 4). The regions that 
deviate most between the two structures include the flexible disulphide loop and the 
first six residues at the N-terminus. Exclusion of these areas from the calculation 
improves the r.m.s deviation to 0.26 A (moll), 0.25 A (mol2), 0.24 A (mol3), and 0.33 
A (mol4). The Ramachandran plot for all four molecules shows 85% of the residues in 
allowed regions and none in disallowed regions. Residues 1 and 2 were not modelled 
due to poor density. Residues 5,88,112,115,179 and 180 in all four molecules and 
residues 91 and 92 in molecules 2,3 and 4 were modelled as alanine due to insufficient 
density. Molecule 1 will be used throughout for discussion.
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Table 3.1 Ciystallographic data collection and refinement statistics________
Cell Dimensions (A) a = 126.9, b = 101.3, c = 82.0
Space group P2i2i2 4 mol/a.u.
Resolution (A) 40.0-2.8
No. of measurements 144123
No. of unique reflections 26185
Completeness 95.8(61.3)"
I/a 6.5 (5.3)
IW (% )b 10.8 (28.5)
Refinement 
I W % )C 21.4
28
No. of protein atoms 7031
No. of water molecules 143
Temperature factors (A2)
Main chain* 28.4,30.1,24.9,43.5
Side chain 30.4, 332,28.5,45.1
Zinc ligands 29.3,34.2,23.2,52.0
Zinc ions (average) 48.0
RMSD in bond lengths (A) 0.007
RMSD in bond angles (A) 1.32
* Outermost shell 2.9-2.8 A.
b Rmerge = Z(1 Ij - <I>I )/£<I>, where Ij is the observed intensity of reflection j and <I> is the average 
intensity of multiple observations.
c Royit -  Zl Fj - 1 Fj /2l F j , where F0 and Fe are the observed and calculated structure factor amplitudes, 
respectively.
d 5% of the data that were used for the calculation of R ^  were randomly excluded from the refinement
* Temperature factors for individual molecules quoted.
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Overall structure
The structure of the SpeAl-zinc molecule is characteristic of the superantigen family 
(Figure 3.4). It contains a long central a-helix, an N-terminal domain and a C-terminal 
domain. Part of the N-terminal domain has a p-barrel topology formed by strands pi,
P2, P3, p4 and p5, similar to the ‘oligosaccharide/oligonucleotide fold’ (Murzin, 1995) 
present in other superantigens. Strands P2 and P3 are anti-parallel, and strand pi is 
parallel to p5 and anti-parallel to P4. Several hydrophobic residues from the P-barrel are 
solvent-exposed. Other structural features of the N-terminal domain include helices a2, 
a3 and a5 and a disulphide bridge in the p4-p5 loop. The C-terminal domain has 
features of the ‘p-grasp motif as seen in the structures of other superantigens 
(Papageorgiou and Acharya, 1997, 2000). With a p-sheet topology packed against the 
central a4 helix. Strands P6, P9, piO and pi2 form a relatively flat surface with strand 
P7 rotated by ~ 30° with respect to P6. The N-terminal tail (residues 3-16) is packed 
against the P-grasp motif, and as such is considered part of the C-terminal domain. 
Structure-based sequence alignment identifies SEC2 as the most similar superantigen to 
SpeAl. The main differences occur due to deletions in the loop regions of the structure. 
SpeAl (221 amino acids) and SEC2 (239 amino acids) also show variability in their 
respective disulphide loop regions.
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site
Figure 3.4: The structure of SpeAl-zinc complex. The bound zinc ion is shown as a blue 
sphere. The disulphide bridge is shown in ball-and-stick representation, the free cysteine, 
which is part of the disulphide loop is also shown.
The disulphide bridge
The SpeAl-zinc structure contains three cysteine residues; two o f them (Cys 87 and Cys 
98) form a disulphide bridge at the top o f the N-terminal p-barrel, between strands p4 
and p5 (Figure 3.4). The third cysteine (Cys 90) is solvent exposed and forms part o f the 
disulphide loop. The disulphide loop is common to all superantigens except SpeC which 
does not contain any cysteine residues in the corresponding region, and TSST-1 which 
does not contain any cysteine residues at all (Papageorgiou et al. , 1999). The disulphide 
loop o f SpeAl is comprised o f ten residues, compared to 19 for SEB, 16 for SEC, and 9 
for SEA. The residues o f the disulphide loop in SpeAl-zinc possess high temperature
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factors, due to the highly flexible nature of this region. The loop is located at the 
interface between the four molecules and is involved in crystal packing interactions. 
However, it still retains some degree of flexibility and superposition of the residues 
within the loop (87-98) shows an r.m.s deviation of 0.52 A (mol l-mol2), 0.28 A (mol 
1 -mol 3) and 0.64A (moll-mol4).
The zinc binding site
The crystal structure of the SpeAl-zinc complex revealed the presence of a zinc binding 
site at the interface between the N- and C-terminal domains of SpeAl (see Figure 3.4) 
the zinc ligands are Glu 33, Asp 77, His 106, and His 110. (Figures 3.5 and 3.6). In the 
presence of the zinc ion, slight movement of the surrounding residues can be observed 
compared to the previously determined native structure of SpeAl in the absence of zinc 
(Papageorgiou et al., 1999). The distances between the ligands and the zinc ion are Glu 
33 OE1- 1.98 A, Asp 77 OD1 -  2.47 A, His 106 ND1- 2.06 A, and His 110 NE2- 2.17 
A. These values are comparable to those from other zinc binding superantigens, and fall 
within the range of distances documented by Alberts et al. (1998) for tetrahedrally co­
ordinated zinc ions in proteins. A similar study was recently conducted by Earhart et al 
(2000). They reported an identical site in the structure of SpeAl (3.0 A; 65% complete 
data) to the one presented here. In addition, a cadmium binding site involving residues 
87-98 from the disulphide loop was also identified. However, no attempt was made to 
address the biological significance of these sites. The work presented here aims to 
further characterise the zinc site of SpeAl and assess its implications for MHC class II 
recognition by SpeAl.
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Figure 3.5: Comparison of the zinc binding site of native SpeAl (white) and zinc complexed 
SpeAl (grey).
The presence o f a zinc site in SpeAl was originally proposed by by Papageorgiou et al 
(1999) on the basis o f sequence comparison and the crystal structure o f SEC2. The 
residues Asp 77, His 106, and His 110 o f the SpeAl-zinc binding site are structurally 
equivalent to the residues Asp 83, His 110, and His 122 in SEC2 with the fourth zinc 
ligand being formed by Asp 9 o f a symmetry related molecule in the crystal lattice. The 
SEA structure contains two zinc binding sites -  one on the N-terminal domain and one 
on the C-terminal domain (Schad et al., 1997; Sundstrom et al., 1996). The SEC2-like 
zinc binding site o f SEA (N-terminal domain) also has three ligands o f structural 
equivalence to SpeA l: Glu 39 (Glu 33 in SpeAl), Asp 83 (Asp 77), and His 118 (His 
106), with a water molecule in SEA replacing the second histidine residue (His 110) 
found in SpeAl (Schad et al., 1997). Different and structurally non-equivalent zinc 
binding sites have been identified in SEA (Schad et al., 1997; Sundstrom et al., 1996), 
SED (Sundstrom et al., 1996), SEH (Hakansson et al., 2000), and SpeC (Roussel et al., 
1997). As a result, several putative roles for zinc in the structure o f  the superantigen
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family have been proposed.: the zinc ion has been shown to have a role in in the 
formation o f (a) stable homodimers (for SED and SEH); (b) a second high affinity 
MHC class II binding site (for SEA, SEC, SED, and SEH); and (c) in the 
thermostability o f the superantigens.
Figure 3.6 The electron density of the SpeAl zinc binding site. 2|F0| — |FC| map contoured at 1 
a. The orientation is the same as in Figure 3.5.
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To confirm that the residues Glu 33, Asp 77, His 106, and His 110 comprise a zinc 
binding site, mutant forms of SpeAl with Ala substituted at each of these positions 
were generated and the affinity of each of these forms for zinc was determined by 
equilibrium dialysis (work carried out by our collaborators, Professor Carleen Collins, 
University of Miami Medical School, Miami, FL, USA.) (Baker et al., 2001). The Kd of 
SpeAl for zinc was determined to be 2.3 pM, which is approximately 10-fold higher 
than the Kd of the SEA-zinc interaction (0.3 pM) (Sundstrom et a l, 1996). The Kd of the 
mutant form of SpeAl- Asp 77 Ala for zinc was 60 pM, of SpeAl-His 106 Ala for zinc 
was 120 pM, and of SpeAl-His 110 Ala for zinc was 80 pM, indicating that the affinity 
for each of these mutant toxins for zinc was significantly decreased compared to the 
affinity of wild type toxin for zinc. The SpeAl-Glu 33 Ala-zinc interaction had a Kd of
5.8 pM, which represent only a slight decrease in affinity. No zinc binding was 
observed with the double mutant SpeAl-Asp 77 Ala, His 106 Ala when 150 pM of 
toxin was used in the experiment, indicating that the Kd of zinc for this mutant was 
much greater than 150 pM. Thus, the residues Asp 77, His 106, and His 110 are clearly 
necessary for zinc binding, while Glu 33 has a lesser role.
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A possible role for the zinc ion in MHC class II recognition?
SEA has two distinct MHC class II binding sites, one at the C-terminus and the other at 
the N-terminus. The C-terminal binding site contains a zinc ion, and has an approximate 
100-fold higher affinity for MHC class II than the N-terminal MHC class II binding site 
(Abrahmsen et al., 1995). The generic N-terminal MHC class II binding site does not 
contain zinc, and is similar to the MHC class II binding sites found in other 
superantigens such as SEB and SEC. There is evidence to suggest that SpeAl also 
contains a generic MHC class II binding site. A previous study examining the affinity of 
various SpeAl mutants for MHC class II indicated that mutations at SpeAl residues 42 
to 48 decrease binding to the MHC class IIDQ molecule (Kline and Collins, 1996). 
SpeAl residue Leu 42 is conserved in the SEB generic MHC class II binding site. 
Therefore, it is possible that SpeAl is similar to SEA in that it has two distinct MHC 
class II binding sites: a generic site, and a zinc-mediated site. The positions of the two 
predicted binding sites on within the structure of SpeAl is similar to the positions of the 
MHC class II binding sites seen in the structure of SEC2 (Papageorgiou et al., 1995). 
Mutagenesis studies have shown His 81 of the MHC class II P-chain to be important for 
the zinc-mediated binding of SEA to the MHC class II molecule (Fraser et a l, 1992).
To examine the possible interactions of SpeAl with MHC class II molecules via its zinc 
site, SpeAl was docked onto mouse HLA-DR1 (Figure 3.7). The theoretical model 
gives a good overall fit for the interaction of the zinc site of SpeAl and His 81 of the 
DR1 P-chain. There are only minor clashes in the model involving residues Leu 111,
Ala 112, and lie 113 (from strands P5 and P6) of SpeAl with part of the antigenic 
peptide bound in the peptide binding groove of HLA-DR1. However, it should be noted 
that peptide antigen varies greatly throughout the MHC class II population (Chicz et al,.
1992). And several peptides have been shown to either enhance or reduce the affinity of
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superantigens for MHC class II, depending on their interactions with the superantigen 






MHC class II 
Binding site
Figure 3.7: Proposed model for DR 1-SpeAl-zinc mediated recognition. In this mode of binding, 
His 81 from the P-chain of the MHC class II molecule would replace one of the zinc binding 
ligands from SpeAl (inset)
The modelled complex gives clues to the proposed zinc-mediated binding o f SpeAl to 
HLA-DR1 (Figure 3.7). When His 81 o f the DR p-chain binds to the toxin via the zinc 
ion, there would be some rearrangement that would affect the overall geometry o f the 
site, and therefore, the position o f neighbouring residues allowing the optimisation of  
favourable contacts between the superantigen and the MHC class II molecule. It should 
be noted that in the present modelling exercise we used the co-ordinates o f the SEB- 
DR1 complex (Jardetzky et al., 1994), and that SpeAl has preferential binding for
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HLA-DQ. However, His 81 and its neighbouring residues are conserved in HLA DQ 
(Schiffenbauer et al., 1987).
The recent structures of SpeC in complex with HLA-DR2 (Li et al., 2001) and SEH in 
complex with HLA-DR1 (Petersson et al., 2001) confirms this mechanism of action. 
Both SpeC and SEH show extensive and similar contact with the class II associated 
antigenic peptide have similar interactions with the antigenic peptide even though they 
are different This indicates that the interactions seen in the SpeAl-DR1 model between 
SpeAl and the antigenic peptide are also required for optimal superantigen/MHC 
binding.
There are at least four naturally occurring SpeA alleles, and three of these, SpeAl, 
SpeA2, and SpeA3 encode for toxins that differ from each other by a single amino-acid 
(Musser et al., 1991). SpeA3 differs from SpeAl by a single amino Val to lie 
substitution at position 76. SpeA2 differs from SpeAl by a single Gly to Ser 
substitution at position 80. In the SpeAl structure, both Val 76 and Gly 80 are buried. 
The allelic variants of SpeA show different binding affinities for HLA-DQ with K|S of 
104,55, and 13 pM for SpeA 1,2, and 3 respectively. SpeA3 is the most mitogenic of 
these alleles, and appears to exhibit a higher affinity for HLA-DQ than SpeAl (Kline 
and Collins, 1996). It is tempting to suggest that the proximity of this allele specific 
amino acid residue to the zinc binding site of SpeA3 (adjacent to Asp 77) may play a 
role in the increased affinity for HLA-DQ. Furthermore, it has been shown that a 
variant of SpeAl, Asp77Ala, has a much lower ability to bind HLA-DQ (Hartwig et al.,
1993). In addition, it is interesting to note that Ser 80 in SpeA2 is also located in close 
proximity to the zinc binding site of SpeAl and to residues implicated in TCR binding. 
Clearly the role of these two residues needs to be investigated further. However, the 
presence of a zinc site does offer an alternate mode of MHC class II recognition by
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SpeAl, and perhaps the possibility of additional interactions with MHC class II 
molecules to accommodate multiple TCR molecules. Superantigen dimerisation as a 
prerequisite for T cell activation has been suggested for SED (Sundstrom et a l , 1996) 
and SpeC (Roussel et a l, 1997).
The TCR binding site
SpeAl binds to, and activates human T cells bearing Vpi2.2, Vpl4.1 and VP2.1 (Kline 
and Collins., 1997) (Lavoie et a l, 1999). It has been shown that SpeAl utilises different 
residues depending on the TCR Vp chain (Kline and Collins, 1997); a mechanism that 
has become evident from the known superantigen structures so far. The dissociation 
constant for the mouse TCR VP8.2 is in the same range as that of SEC2 (6.2 and 7.9 
|iM, respectively) (Malchiodi et a l, 1995). Based on the structural similarities of SpeAl 
to SEC2 in combination with mutagenesis data, the TCR-binding site encompasses 
residues from the a2 helix, P2-P3 loop, the disulphide loop, a4-P9 loop, and the a5 
helix.
As with other superantigens, high sequence variability and high flexibility is a common 
feature of the SpeAl TCR binding site (Papageorgiou and Acharya, 1997). For 
example, Gly 19 in SEC2 is replaced with Lys 16 in SpeAl and this may affect the 
number of contacts with the TCR Vp chain. Asn 20 in SpeAl is conserved in all 
superantigens and has been shown to play a critical role in the TCR binding.
The disulphide loop appears to be important for interactions with both the TCR and 
MHC class II. The conformation of the disulphide loop between Cys 87 and Cys 98 has 
been shown to be important for MHC class II binding (Kline and Collins, 1996; 
Roggiani et a l, 1997). In SEC2, four residues from the disulphide loop could make 
potential contacts with the complementarity determining region 1 (CDR1) chain and
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Gin 72 of Vp. The disulphide loop of SpeAl is significantly shorter and these 
interactions may not be feasible. However, Cys 90 and Cys 98 from the disulphide loop 
of SpeAl are required for stimulation of Vp 12.2 expressing T cells (Kline and Collins,
1997), with Cys 90 being essential for Vpi2.2 T cell stimulation, and to a lesser extent 
for Vpl4.1, whilst having no observable influence on the stimulation of Vp2.1 
expressing cells (Kline and Collins, 1997).
SpeAl recognition and binding modes
It is proposed that superantigen recognition and complex formation can occur by several 
different modes of action (Figure 2.7) depending on the superantigen involved. For 
example dimerisation of SED (Sundstrom et al., 1996) and SpeC (Roussel et a l , 1997) 
has been suggested as a prerequisite for T cell ativation. Previous data for SpeAl 
suggests that this toxin could also act as a dimer under certain conditions. During the 
purification of recombinant SpeAl at pH 7.9 approximately 50% of the purified protein 
is in a biologically active, disulphide linked dimeric form (Papageorgiou et al., 1999). 
Thus the combination of generic and zinc-dependent MHC class II binding sites with a 
dimeric form of the toxin would allow SpeAl multiple modes of interaction with both 
MHC class II molecules and T cell receptors.
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Chapter four
The Crystal Structure of Staphylococcal
Enterotoxin B T-cell Variant
Thr 112-Ser
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Introduction
Staphylococcal enterotoxin B (SEB), a primary cause of food poisoning is also 
responsible for a significant percentage of non-menstrual-associated toxic shock 
syndrome in patients with a variety of staphylococcal infections. These include 
surgical and postpartum wound infections, deep abscesses, bums, abrasions, insect 
bites, sinusitis, and influenza-associated super-infections of the respiratory tract 
(MacDonald, 1996, Lowell, 1996) (Schlievert, 1993). The case fatality rate for toxic 
shock syndrome can be up to 50% (Freedman, 1991) and in influenza associated 
cases, mortality can reach 90% (Schlievert, 1993). SEB is considered to be the most 
potent of the staphylococcal superantigens and in an aerosolised form, is considered a 
potential biological warfare threat; causing incapacitation, shock and death in soldiers 
and civilians.
The high resolution structure of SEB (1.5A) (Papageorgiou et a l , 1998) along with 
the crystal structure of SEB in complex with HLA-DR1 (Jardetzky et al., 1994) and 
TCR Vp (Fields et a l , 1996) has allowed a detailed analysis of the functional domains 
of SEB. As such, it is often cited as the prototypic superantigen (Papageorgiou and 
Acharya, 2000). The TCR binding site lies between the two domains of the toxin in a 
shallow cavity formed by residues 20 -  33 (mostly a2 helix), 55 -  61 (02 -  03 loop), 
87 -  92 (0 4 ,0 4 -0 5  loop), 112 (05), 177 (a4 -  09 loop)210 -  214 (a5) (see Figure 
4.1). The MHC class II binding site is located primarily in the N-terminal domain of 
the toxin and comprises of residues 44 -  47 (01 -  02 loop) 65 -  69 (03,03 -  a3 loop), 
89 (04), 92 -  96 (04 -  05 loop), 115 (05), 211-215 (a5) (Jardetzky et a l , 1994). It is 
apparent that several of the TCR binding residues and MHC class II binding residues 
juxtapose each other.
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Figure 4.1: The crystal structure of native SEB. All secondary structure elements are 
labelled (Papageorgiou et al., 1998).
Through mutagenesis o f individual amino acids, it is possible to further assess each 
residues contribution both to the functionality o f the toxin and to the overall structure 
o f the toxin. The Thr 112 Ser variant was selected for study in order to assess the 
functional and structural contribution o f this residue to the binding o f TCR by SEB. 
Thrl 12 has been proposed to be involved in SEB -  TCR interactions previously 
(Swaminathan et al., 1992). However this residue is buried in the high resolution 
structure (Papageorgiou et al., 1998). As such, it is presently unclear what role 
threonine 112 plays in TCR binding in SEB. This study undertook to elucidate the 
crystal structure o f SEB Thr 112 Ser. In order to examine any possible effects that this
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mutation might have on the toxins ability to interact with the TCR its structure was 
compared to that of free and TCR complexed SEB.
Materials and Methods 
Expression and purification of SEB Thr 112 Ser
Purified protein was supplied by Dr Rick Titball, CBDE, Porton Down, Salisbury, 
UK. The procedure adopted was as follows. The recombinant plasmid pMALc2 
encoding SEB Thr 112 Ser -maltose binding protein fusion protein were transformed 
into E. coli X I776. These recombinant bacteria were cultured in tryptone soya broth 
(Oxoid) supplemented with the following to the final concentrations indicated: 20 
mM Tris -  HC1 pH 7.5,5 mM magnesium chloride, 0.5 % (w/v) glucose, 0.01 % 
diaminopimelic acid, 0.005 % (w/v) thymidine and 50 pg/ml ampicillin. 400 ml 
cultures were incubated at 37 °C with shaking at 180 rpm. IPTG was added to a final 
concentration of 0.5 mM at an A^ oo of 0.7. Cultures were incubated for a further 3.5 
hours and the cells harvested by centrifugation at 12,000 x g, 4°C for 10 minutes. The 
cells were resuspended in 30 ml of column buffer; 20 mM Tris -  HC1 pH 7.4, 
containing 200 mM sodium chloride, and 1 mM dithiothreitol. Lysozyme was added 
and the suspension incubated at 20 °C for 30 minutes. Aliquots were sonicated on ice 
for 3 x 20 seconds with 20 seconds rest The crude cell extract was centrifuged at 12, 
000 x g for 30 minutes at 4°C. The filtered supernatant was applied to an equilibrated 
40 ml column and washed with 400 ml of column buffer. 40 ml of elution buffer 
(column buffer containing 10 mM maltose) was added to the drained resin and the 
column rolled for one hour at room temperature. The eluate was collected in 1 ml 
fractions and analysed at 280 nm and by SDS gel. Fusion protein containing fractions 
were pooled and cleaved with 1.6 ml (1600 units) of factor Xa (Amersham 
Pharmacia Biotech Ltd.) in column buffer containing ImM calcium chloride and 0.05
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% SDS (w/v) overnight. The cleaved product was dialysed against 25 mM Tris -  HC1 
pH 8.0 containing 20 mM sodium chloride overnight and then filtered using a 0.22 
pM filter. The filtered sample was the applied to a Mono Q anion exchange column 
and the run-through containing the cleaved toxin was collected. Pooled fractions were 
then concentrated by stirred cell ultrafiltration (Millipore U.K. Ltd) and assessed for 
purity and quantity by SDS gel and Coomasie blue dye binding assay (Biorad Ltd).
Crystallisation
Crystals of SEB Thr 112 Ser variant were grown at 16°C using the hanging drop 
vapour diffusion method. Samples (2pl) of the reservoir solution (0.8ml) containing 
30 % (w/v) PEG 4000,50mM sodium citrate buffer (pH 4.6), and 0.1 M ammonium 
acetate were mixed with an equal volume of protein stock solution (10 mg/ml) on 
siliconized cover slips. After several months crystals formed in the orthorhombic 
space group P2j2i2i with two molecules in the asymmetric unit The crystallisation 
conditions and molecular packing in the variant structure differs from that previously 
reported for the native SEB toxin (Papageorgiou et al., 1998). Native SEB crystallised 
as a monomer, whilst the Thr 112 Ser variant forms crystals as a dimer.
88
Chapter 4 Staphylococcal enterotoxin B T 112S variant
Data collection
Diffraction data were collected at 100K using crystallisation buffer as cryoprotectant. 
The first data set was collected to 2.0 A at the synchrotron radiation source, Trieste, 
Italy using a Mar 345 image plate. Seventy nine images were collected with an 
oscillation range o f 1.5° per image. A second data set (55 images) was collected at 
Daresbury, PX 9.5 to 1.8A with an oscillation range o f 1.5° using a MAR CCD 
detector. Data processing, scaling and merging o f the two data sets was carried out 
using the HKL suite (Otwinowski and Minor., 1997). The final Rmerge was 11% with 
an overall completeness o f 92.7%. The data processing statistics are given in table 
4.1.
1.8A
Figure 4.2: Diffraction image of SEB Thr 112-Ser variant crystal.
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Structure determination and refinement
The structure of SEB Thr 112-Ser variant was solved using molecular replacement 
with the program AMoRe (Navaza, 1994) using the native 1.5A native SEB monomer 
as the search model (Papageorgiou et al., 1998). Clear solutions were found for the 
two models in the asymmetric unit as follows;
SolutionF 146.48 45.05 100.83 0.0091 0.3603 0.0902 65.9 38.7 
SolutionF 36.43 132.01 285.80 0.4218 0.6885 0.8620 65.9 38.7
The resulting structure was subject to rigid body refinement and the calculation of an 
electron density map. The structure was refined by simulated annealing using the 
maximum likelihood target as implemented in the program CNS (Briinger et al.9
1998) with non-crystallographic symmetry (NCS) restraints. The progress of the 
refinement was followed by monitoring both R^e and Rcryst (BrQnger et a!., 1992) 
values. The refinement was continued using cycles of simulated annealing and 
individual B-factor refinement followed by model rebuilding. Electron density maps 
(I F j -I F j and 2(1 F j -I F j ) weighted at 2a were calculated after each cycle of 
refinement and visualised using the program *0’ (Jones et al.91991). Water molecules 
were added to the model manually based on the density seen in the electron density 
maps, and also by using the water pick protocol in CNS. In the final rounds of 
refinement the NCS restraints were gradually released and the two molecules were 
checked and refined individually. The final model has a cry stallographic R-factor 
(Rcryst) of 22.8% for all the data from 40 -  2.0A resolution, and an Rfce of 26% for 
5% of the data omitted.
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Table 4.1 Crystallographic data collection and refinement statistics
Cell Dimensions (A) a =39.5, b =98.5, c = 126.5
Space group P212121; 2 mol/a.u.
Resolution (A) 40.0-2.0
No. of measurements 419612
No. of unique reflections 33201
Completeness 92.7 (88.3)*
I/o 7.1 (2.9)
i W ( % ) b 11.0(36.5)
Refinement
Rcry*(%)C 22.7
U K / 24.6
No. of protein atoms 3801




RMSD in bond lengths (A) 0.007
RMSD in bond angles (A) 1.169
* Outermost shell 2.1-2.0 A.
b Rnicrge = Z(l Ij - <I>I yZ<I>, where Ij is the observed intensity of reflection j and <I> is the 
average intensity of multiple observations.
c Rayst = ZlFj - 1 Fj /Zl F j , where F0 and Fc are the observed and calculated structure factor 
amplitudes, respectively.
d 5% of the data that were used for the calculation of were randomly excluded from the
refinement
e Temperature factors for individual molecules quoted.
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Results and Discussion 
Quality of the structure
The three dimensional structure of Thr 112 Ser-SEB variant was determined at 2.0 A 
resolution. The data collection and refinement statistics are shown in Table 4.1. The 
final model contains 3S02 non-hydrogen protein atoms with temperature factors in the 
range of 5-85 A2 and 173 water molecules with temperature factors <45 A2. The root 
mean squares (r.m.s) deviation between monomer pairs for the variant is 0.54A, 
between the variant and native SEB structures is 0.82 A respectively. The regions that 
deviate most between the native and mutant structures include the disulphide loop, the 
first 20 residues at the N-terminus, and residues 41 to 62. Exclusion of these regions 
improves the r.m.s deviation to 0.43A. The Ramachandran plot for both molecules 
shows 87.1% of the residues in the most favourable regions and no residues in the 
disallowed regions. Residues 98 to 107 have not been modelled due to poor density 
and residue 238 in both molecule 1 and molecule 2 was modelled as alanine due to 
insufficient density. Molecule 1 will be used throughout for the discussion.
General Architecture and comparison with other prototype 
superantigens
The architecture of SEB Thr 112-Ser variant is essentially identical to that of native 
SEB and similar to that of other superantigens (Figures 4.1 and 4.5). Figure 4.6 shows 
an overlay of the Ca-traces of both variant (black) and native (grey) SEB. Residues 7 
to 10 are rotated by 180° with respect to the native SEB structure. Even in the 1.5 A 
native structure, this region was poorly defined with B-factors in the range of 70 -  
125 A2; compared to B-factors in the range o f30 -  40 A2 and good quality electron
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density in the Thr 112 Ser variant. The disulphide bridge formed by Cys 93 and Cys 
113 is intact in the native structure; those residues o f the disulphide loop that have 
been modelled are in a slightly different conformation to that o f the native structure, 
although this is to be expected as the highly flexible nature o f the loop makes it hard 
to model. The disulphide loop o f SEB encompasses 19 residues compared to nine in 
SEA and 16 in SEC2 and extends some 12A from the body o f SEB (Papageorgiou et 
al., 1998) into the solvent.
Figure 4.3: The electron density at the mutation site clearly indicates a density for 
a serine side-chain. 2 |F0| -  |FC| map contoured at 1 a.
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Figure 4.4: A representative portion of the electron density map at 2 A contoured at 1 a.
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ser 112
Figure 4.5: Ribbon diagram of SEB T112S monomer. All secondary structure elements are 
labelled (top). The 310 helical turn in the C-terminal domain is labelled a-1. The mutation site is 
circled. Inset; the mutated threonine residue is labelled along with the TCR binding residues Asn 
60 and Tyr 61.
Bottom: the arrangement of monomers to form the ncs dimer in the variant structure.
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Crystal packing -  Differences in the native and SEB Thr 
112-Ser variant structures
Both native SEB and SEB Thr 112-Ser variant crystallise in the space group P2i2i2i. 
Unlike native SEB which has one molecule in the asymmetric unit, Thr 112 Ser 
crystallises with two molecules in the asymmetric unit (Figure 4.5). The buried 
surface area at the interface between the two monomers is 1477A2. Upon dimer 
formation, a loss of approximately 10% of the accessible surface area is seen for each 
monomer, which is consistent with results from other protein-protein interfaces. 
Contact between the two monomers is mediated by several residues (Table 4.2). 
Interestingly, some of the contact between the two molecules is mediated by residues 
(58 and 59 in mol 1 and 54 and 58 in mol2) in the p2~p3 loop region (residues 53 to 
61) which is involved in TCR binding and recognition (Table 4.3). In the Thr 112 Ser 
structure this loop is located at the dimer interface and residue 109 is involved in 
packing interactions with the N-teiminal of mol 2.
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Figure 4.6: Cot trace of native SEB (black) overlayed with T112S variant (grey). View is tilted 
180° forwards with respect to the standard view. The mutation site is located in the top right 
hand comer.
Cut o f f  values: C-C 4.1 A, C -N  3 .8  A, C -0  3 .7  A, 0 - 0  3 .3 A, 
0 - N  3 .4A , N -N  3.4A .
Thr112 / S e r 112
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The TCR binding site
Mutagenesis and structural studies have identified regions 20 -  33 (a2 helix), 55 -  61 
(p2-p3 loop), 87 -  91 (p4), 112 (p5), 177 (a4-p9 loop), 210 -  214 (a5) as being 
crucial for T cell receptor binding in SEB (see Figure 4.7 A, 4.7 B and Table 4.3). 
Contact in the SEB/TCR complex is between SEB side-chain atoms and TCR Vp 
backbone atoms; mainly CD1, CDR2 and HV4 regions (Fields et aL, 1996). Asp 23; 
located in the a2- helix region is invariant among the superantigens and has been 
shown to be important in forming the core of TCR binding residues (Kappler et a l ,
1992). Val 26 which is solvent exposed and situated in the middle of the a2 helix is 
also involved in SEB TCR binding. It has been shown that the corresponding residue 
in SEC1 and SEC2 confers differing TCR Vp specificities on the two toxins. Also in 
this region of SEB are Asn 31 (solvent accessible) and Val 33 (buried) both of which 
are implicated in TCR binding specificity.
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Figure 4.7: Close up stereo view of the TCR site of native SEB (top), SEB in 
complex with TCR Vp chain (middle), and SEB Thr 112-Ser variant (bottom). 
All residues in the putative TCR binding site are shown, note the movement of 
the p2-p3 loop (residues 55 -  61) in the T112S TCR site.
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Table 43: Contact between TCR Vp and SEB for the complex, native and variant forms of 
SEB.
Hydrogen Bonds
TCRVP SEB Residue Bond length Bond length Native Bond length Thr 112
residue No. Complex Ser variant
G53 O Q210 N 3.24 3.17 3.71
T55 N N23 O 3.36 338 3.36
O N23 N 3.69 3.46 3.72
K57 Nb T18 O 3.08 3.02 3.14
P70 0* N60 N 337 3.02 143
Van der Waals contacts (<4.0A)
TCR Vp residue SEB Residue No. Complex Native Thr 112-Ser
varaint
H47 L20 ✓ ✓ y
F177 ✓ ✓ y
Y50 Y91 ✓ ✓ y
A52 Y9o ✓ ✓ y
G53 N23 ✓ ✓ y
E22 y ✓ y
F177 y y y
E56 L20 ✓ y y
N23 y y y
K57 Ti8 y y y
Gi9 y y y
L20 y' y y
Y65 F177 ✓ y y
Y66 F177 ✓ y y
A67 F177 y y y
P70 N60 ✓ y X (19.55A)
S71 N60 ✓ y X (20.01 A)
Comparison of the contacts between the TCR Vp Chain and SEB, * refers to the first complex 
molecule in the asymmetric unit, and b refers to the second. Data for the complex are from Li 
et al (1998), data for the native are from the 1.5A structure Papageorgiou et al (1998). 
Distances were calculated for both native and variant forms by superimposing each structure 
on the SEB/TCR complex structure.
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The p2-p3 loop (residues 55 -61) is flexible. The positioning of this loop may affect 
binding to TCR and/or MHC class II and the solvent accessibility of residues such as 
Asn 88, Tyr 89 and Thr 112 (Figure 4.7A, B, and C). Two residues in this loop, Asn 
60 and Tyr 61 are conserved in SEB, SEC and SpeAl and have been implicated in 
TCR interactions (Kappler et a l , 1992) (Papageorgiou et a l,  1999). Tyr 61 in SEB 
and SEC2 is partially hidden by Tyr 90 and Thr 112 which in turn are implicated in 
TCR recognition. Thr 112 is buried and as such its affects on TCR recognition are 
likely to be indirect, for example by perturbation of the local environment such as its 
hydrogen bond to Tyr 89 which is implicated in TCR and MHC binding 
(Papageorgiou et a l, 1998). The residue Phe 177 is situated within the a4-p9 loop. 
The loop is a putative TCR interaction region and Phe 177 makes several contacts 
with the TCR Vp backbone in the SEB complex (Li et a l, 1998). The final region of 
interest in the site is the a-5 helix and in particular, residue Gin 210. Gin 210 is 
involved directly in TCR binding in SEB through hydrogen bonding with the Vp 
main-chain.
Analysis of the structure of the Thr 112 Ser variant reveals that many of the gross 
features of the TC binding site are preserved sufficiently to allow interaction with the 
TCR.
The Mutation site
In the native SEB structure, Thr 112 forms a hydrogen bond with Tyr 89 and has van 
der Waal contact with Tyr 61. The mutation of Thr 112 to Ser causes the loss of the 
hydrogen bond with Tyr 89 and more dramatically the van der waals interaction with 
Tyr 61. As a result the loop region 52 to 64 moves by up to 20 A causing the distance 
from Thr 112 to Tyr 61 to be ~12A (Figure 4.7, Table 4.3). This loop region is 
already quite flexible and is stabilised by interaction with Thr 112 in the native
101
Chapter 4 Staphylococcal enterotoxin B T112S variant
structure. The movement of Tyr 61 has implications for T cell recognition 
(Papageorgiou et a l, 1998 ) (Hayball and Lake, 2000). Asn 60 is also located in this 
loop and forms part of the TCR binding site. In the variant structure Asn 60 has 
moved some 14A from its original position. Leder et al (1998) calculated the 
energetic contribution of the TCR binding site and found that Asn 60 has a modest, 
yet significant contribution to the overall binding of SEB to TCR. It was also found 
in binding studies that mutation of Asn 60 resulted in less efficient stimulation o f T 
cells. Superposition of SEB Thr 112-Ser onto the SEB-TCR complex (Li et a l, 1998) 
by least squares superposition reveals that both Asn 60 and Tyr 61 cannot make their 
usual interactions with the TCR Vp chain. The remainder o f the contacts in the 
complex are also present in the docked Thr 112 Ser variant -  TCR modelled complex. 
A secondary affect of mutation of Thr 112 to Ser and the subsequent movement of 
the P2 - P3 loop is the exposure of Thr 112 to the solvent In this state, Ser 112 forms 
a hydrogen bond with water molecule 47 (2.88 A )  in a position equivalent to Tyr 61 
in the native structure. In turn, this water molecule interacts with a second water 
molecule (3.04 A ) ,  forms a hydrogen bond with Asn 63 (2.86 A )  and interacts with 
the sidechain of Val 64. These interactions help to stabilise the local environment of 
the mutation site in the absence of the P2 - P3 loop. The altered orientation of the p2 - 
P3 means that it was not possible to carry out energy minimisation of Thr 112-Ser 
when docked onto TCR. For this reason, no model is shown.
Biological effects
The SEB Tyr 61 deletion mutant (SEBA61Y) described by Hayball et al (Hayball and 
Lake, 2000) is able to bind MHC class II molecules as wild type, but behaves as an 
altered ligand for a T cell clone (AC20) that expresses the Vp 17 TCR. SEBA61Y
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possessed the ability to partially activate T celled based on its capacity to induce TCR 
down-regulation and IL-2 receptor up-regulation, but failed to elicit the secretion of 
IL-2, IL-3, IL-4, IFNy or cell proliferation. Similarly, substitution of Tyr61 for alanine 
also causes a change in its Vp usage profile (Hayball., 1994).
Work carried out in collaboration with the laboratories of Drs. R. Titball and M.A 
Kehoe (CBDE, Porton Down, Salisbury, UK) indicates that the Thr 112 Ser variant is, 
like Tyr 61 mutants, able to bind MHC class II molecules like wild type toxin. In a 
fashion analogous to the Y61 mutants, the TCR Vp profile was also changed for the 
Thr 112 Ser variant compared to wild type response. SEB is known to selectively 
activate human V p  3, V p  12, V p  14, V p  15, V p  17 and V p  20 T cells. Results from 
experiments performed by our collaborators indicated that both SEB and Thr 112 Ser 
variant selectively induced T cells bearing V p  3.1 and V p  12. Thr 112 Ser variant and 
native SEB activated T cells bearing V p  12 to an equal degree. However, Thr 112 Ser 
variant activated V p  3.1 bearing T cells in the range o f24 -  86 % less than native 
toxin. These data suggest that the specificity of the toxin towards different V p  types 
has been altered by the introduction of the serine residue at position 112, although the 
mutation has a more subtle effect on TCR recognition than 60-61 mutants.
MHC class H binding site
The MHC class II binding site as defined by Jardetzky et al (1994) and Papageorgiou 
et al (1998) appears to be intact in the Thr 112 Ser varient structure. This site is 
formed by residues Phe 44 to Phe 47, Glu 67, Tyr 89 to Ser 96, Tyr 115, Asp 209 and 
Ser 211. The loss of the hydrogen bond between Thr 112
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and Tyr 89 seems to have no effect on the architecture of the MHC class II binding 
site as an overlay of native SEB and Thr 112-Ser reveals all the residues to be in 
equivalent positions. However, it is unclear if the loss of this interaction would come 
into play during complex formation yet, MHC binding studies show little or no 
difference in affinities between SEB and SEB Thr 112-Ser (Baker et a l, 2001).
Unlike most of the other superantigens, SEB does not possess a zinc binding site as an 
alternate mode for MHC class II interaction. This highlights the fact that various 
superantigens have evolved through slightly different mechanisms for their interaction 
with the immune system.
Conclusions
Clearly, the mutation of Thr 112 to serine has significant effect on T cell response. It 
would seem that Thr 112 effects TCR binding indirectly through maintaining the local 
environment of the TCR binding site through its contacts with Tyr 61 and Tyr 89 
(Papageorgiou et a l, 1998). Unlike Tyr61 deletion mutants, the ability of Thr 112 Ser 
to stimulate particular subsets of T cells is maintained, but generally at a diminished 
level. Hayball and Lake (2000) propose that residues Asn 60 and Tyr 61 confer 
specificity for human TCR Vp 17 and murine TCR Vp 7 and 8.1. In the case of Thr 
112-Ser, the TCR Vp repertoire was the same as wild type SEB except that Thr 112- 
Ser stimulated Vp 3.1 to a lesser extent. In this study human Vp 17 TCR were not 
stimulated by either variant or wild type toxin.
Vp profile does differ between Thr 112 Ser and wild type, but in the Tyr 61 variant, 
activity is lost not reduced as is the case for the Thr 112 Ser variant, so this suggests a 
difference between Thr 112 Ser variants and Tyr 61 variants. Structurally these 
altered specificities could be accounted for by several ways. Firstly, it is important to
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note that residues 60 and 61 are located in the middle of a loop region. The flexibility 
of this loop appears to have increased due to the loss of stabilising interactions with 
Thr 112. Therefore it is possible that for a proportion of those superantigens binding 
to TCR; the loop and hence these residues, are in a (near) correct orientation. In turn, 
this could be dependant on the architecture of particular Vp chains.
Secondly, contact with the TCR Vp chain in these positions could be preserved by a 
network of water molecules replacing Tyr 61 and Asn 60 being replaced by Lys 109. 
In the model of Thr 112 Ser complexed with TCR Vp the N atom of Lysl09 is in the 
same region as the N atom of Asn 60, which hydrogen bonds with the TCR Vp chain. 
However, it should be noted that Lys 109 is located at the interface between the two 
molecules in the cry stallographic dimer, forming a contact with both residue 17 and 
18 of the second molecule. As such it would be impossible to distinguish between any 
possible role that this residue would have in TCR binding and dimmer formation with 
the current structure.
The variant produced has a reduced mitogenicity and therefore has the potential for 
use as a vaccine or therapeutic agent However, care needs to be taken when assessing 
a TCR binding site mutants potential as a vaccine as it is possible to create a 
superantigen with altered TCR specificity or increased affinity.
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Introduction
Toxic shock syndrome (TSS) was originally described in 1978 by Todd et al, (1978) 
in seven children between the ages of 8 -1 7 , with staphylococcal infection.
More recently, the disease has become almost exclusively associated with tampon use 
in healthy menstruating women. It is now known that TSS also occurs in non­
menstruating women, men, and neonates and has been linked to many bacterial 
infections including pneumonia, osteomyelitis, sinusitis, and skin and gynaecological 
infections.
Staphylococcal TSS primarily affects women between the ages of 15 -  35. In the USA, 
the frequency of the disease ranges from 2 .4 -1 6  cases per 100,000 of the population. 
The highest recorded incidence was in 1980; but, since then, there has been a persistent 
decline, largely due to the decreased use of super-absorbent tampons. Due to this, a 
combination of more effective treatments and increased awareness of the disease, 
mortality is now less than 3%, although recurrences have been reported in 30 -  40% of 
cases (Salandy, 2001).
The crystal structure of TSST-1 (Prasad et al., 1993), (Acharya et a l, 1994), 
(Papageorgiou et a l, 1996) shows the toxin to be composed of a N-terminal domain 
(residues 1 -  89) and a C-terminal domain (residues 101 -194). Mutagenesis and 
structural studies have identified residues of p i, p2 P3, p4, and P5 in the N-terminal 
domain as being involved in MHC class II binding (Kim et a l, 1994). The Crystal 
structure of TSST-1 in complex with an MHC class II molecule (Kim et a l, 1994) 
shows that TSST-1 extends over almost one-half of the conventional antigen binding 
site and contacts both the flanking alpha helices of the histocompatibility antigen and 
the bound peptide (Figure 2.6). Indeed, a series of peptides described Wen et al,.(1996)
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specifically promote TSST-1 presentation by MHC class II molecules , thus they 
differentially influence the presentation o f bacterial superantigens to T cells.
c
Figure 5.1: The structure o f  TSST-1 as a representative form o f  all three variant structures. Secondary structure 
elem ents including the 3 10 helix  are labelled.
Unlike many o f the other superantigens, TSST-1 does not contain a zinc binding site
(Acharya et al., 1994). As such it is limited to its generic site for MHC class II binding. 
The global location o f the TCR site in TSST-1 differs from that o f the other 
superatigens (Figures 5.1 and 5.2). Mutagenesis studies have shown the residues in the 
region 115 to 144 (particularly Tyr 115, and the a2 helix residues -  Glu 132, His 135, 
lie 140, and His 141) are involved in TCR recognition by TSST-1 (Murray et al., 1996) 
(Bonventre et al., 1993). Antibody recognition experiments on these mutants showed 
that mutant toxin 135 retained recognition with monoclonal antibody 8-5-7 and was 
conformationally intact, yet was non-mitogenic. Toxin from a double mutant, 141.144, 
with alanine substitutions at residues 141 (histidine) and 144 (tyrosine), also was
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devoid of mitogenic activity. In this case, antibody recognition was lost Mutant toxins 
115 and 141 were found to possess approximately half-maximal mitogenic activity and 
retained antibody recognition (Bonventre et al., 1993). All of these residues are found 
in, or very near, a cleft formed by resiues 13 -1 9  (a l helix, p i) 61 -  65 (P4), 115 -  
121(P7, P7 - P8 loop, p8), and residues from the a2  helix (Figure 5.1 and 5.10). 
Together these regions form the TCR binding site.
The native TSST-1 structure is notable for its unusual packing in the unit cell (Acharya 
et a l9 1994). The three molecules in the asymmetric unit are arranged such that two of 
them are packed next to each other with the third molecule packed on top. It belongs 
to the orthorombic space group C222i (cell dimensions a = 108.6, b = 177.6, c =
97.5A) but due to its unusual packing also possess pseudo-hexagonal symmetry in the 
space group P6322 ( cell dimensions a = b = 104.1, c -  97.5A) with one molecule per 
asymmetric unit (Acharya et al.9 1994).
Mutant selection criteria and aims
Each mutation site is shown below (Figure 5.2). The residues chosen have 
previously been shown to be important in TCR recognition by TSST-1 and are located 
at the rim of the TCR binding site. The crystal structure o f the biologically inactive His 
135 Ala TSST-1 form of the toxin revealed several important features of the TCR 
binding site (Papageorgiou et al., 1996). The loss of interaction between the mutated 
His residue and the a l  helix causes a significant change in the conformation of the 
helix between residues 14 and 16 making it one residue shorter. This change in 
conformation could not be predicted from modelling studies alone, thus highlighting 
the importance of crystallography in examining the effects of individual amino acid
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substitutions. This structure also highlighted the intricate nature o f the interactions 








Figure 5.2: The TSST-1 TCR binding site is located in the centre of the toxin and 
encompasses residues from the a l  and a2 helices.
It remains to be seen whether inactivation o f the toxin is caused by local or global
conformation changes upon mutating certain amino acids. These mutations may affect 
the TCR binding by disrupting crucial interactions the global fold o f the TSST-1 TCR 
binding site. It is postulated that mutation o f the buried residues Tyr 13 and his 141 
would have some effect on TSST-1 structure (Papageorgiou et a l ,  1996). The effects 
o f a mutation in the 3io helix such as Tyr 174, are unclear at present. In other 
superantigens such as SEB SEC2 and SEA, the TCR binding site is larger and 
encompasses a third helix region into the site (a5 SEB and SEA, a6  SEC2) which is 
analogous to the 3jo helix in TSST-1 (Papageorgiou et a l ,  1996). The aims o f these 
experiments were to purify enough TSST-1 Y13A for crystallisation and subsequent 
data collection and structure solution, and solve the structures on the previously 
crystallised Y174A and H141A mutants. Through examining the structures o f these
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three mutants, it is hoped that their role both in the architecture and function of the 
TCR site can be better understood.
Materials and methods 
Growth and purification of Tyr 13-Ala variant
TSST-1 Tyr 13-Ala was supplied by CAMR in the pEZZXa vector (pharmacia LKB) 
subcloned into E.coli %\776. This construct produces TSST-lTyr 13-Ala protein fused 
with the ZZ domain of protein A for ease of purification with human IgG sepharose 
matrix.
pEZZXa-TSST-1 Tyr 13-Ala was inoculated into 50 ml of Tryptone Soya Broth 
(CAMR media) supplemented as follows; 2% 1M Tris-HCL at pH 7.5, 0.5% of a 1% 
magnesium chloride solution, 1% of 1% diaminopimelic acid, 0.5% of 1% thymidine, 
1% of a 50% glucose solution, and 0.1% of 100 mg/ml ampicillin. Cultures were 
grown overnight at 37° C with constant shaking at 180 rpm, then seeded into two 2.5 L 
flasks containing 250 ml of supplemented media.
Cells were removed by centrifugation at 6000 rpm (Sorvall RC5 centrifuge, GS3 rotor) 
for 15 minutes and the supernatant decanted. Ammonium sulphate was added to the 
supernatant to a final concentration of 60% and the flask left at room temperature for 2 
hours. The precipitated protein was then harvested by centrifugation at 12,000 rpm 
(Sorvall RC5, GSA 3 rotor) for 35 minutes. Protein pellets were resuspended in TE 
buffer to produce a final volume of 30 ml of crude protein extract, and dialysed 
overnight at 4° C against pure water. Aliquots of the extract were analysed by SDS 
PAGE and Western blot.
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Purification of TSST-1 Tyr 13-Ala-ZZ fusion protein from 
crude protein extract
TSST-1 Tyr 13-Ala fusion protein was further purified by affinity chromatography 
using human IgG sepharose matrix (Sigma) a 1.6 cm diameter column (Pharmacia 
LKB technology) and a pharmacia LKB PI pump. Once loaded onto the column the 
sample was washed with 100ml of 50 mM Tris-HCl pH 7.5 with 100 mM sodium 
chloride and the fusion protein eluted with 50 ml of 0.1 M glycerine-HCl (pH 3). 
Fractions were collected in 2 ml aliquots ( flow rate of lml/min) and analysed at 280 
nm. Fractions containing the fusion protein were pooled for further purification.
Factor Xa cleavage of the ZZ domain from TSST-1 Tyr 13- 
Ala and final purification.
50 pg of factor Xa was added per mg of protein, as assessed by its absorbance at 280 
nm, and incubated at room temperature for 48 -  72 hours. The cleaved protein sample 
was then passed through the column again and eluted in the first wash. Purified protein 
fractions were then pooled and assessed for purity by SDS PAGE and Western blot 
(Figure 5.3).
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A 1 2 3 4 5 6
Figure 5.3: Top; the purification and cleavage of TSST-1 Y13A fusion protein. Lane 1. 
Molecular weight markers, 2) TSST-1 Y13A fusion protein, 3) TSST-1 Y13A fusion 
protein 72 our digest with factor Xa, 4)As lane two, 5) As lane three, 6) Molecular 
weight markers. Below; The final purified product as used for crystallisation. Each lane 
contains pure TSST-1 Y13A in successive 1 in 10 dilution (left to right)
Purified TSST-1 His 141-Ala and Tyr 174-Ala variants were supplied by CAMR, 
Porton Down, Salisbury, UK as part o f a collaboration with Dr Howard Tranter.
Crystallisation of TSST-1 Tyr 13-Ala
Crystal screen conditions were initially set up based on the crystallisation conditions o f  
the His 135-Ala mutant o f TSST-1 (Papageorgiou et al., 1996). Using the hanging 
drop method 24 well plates were set up with varying concentrations of PEG 4000 12- 
25% and LiCl (0 .25- 0.85 M). The conditions that gave the best crystals were 0.1M 
sodium acetate (pH 4.6), 12% PEG 4000, and 0.55 M LiCl, and 5 mg/ml protein 
solution.
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Crystallisation of His 141-Ala
Crystals were grown using the hanging drop method in 0.2 M sodium acetate, 25% 
PEG 4000, in Tris/HCl buffer (pH 8).
Crystallisation of Tyr 174-Ala
Crystallisation trials were carried out using the same conditions as TSST-1 H135A 
mutant (Papageorgiou et al. , 1996) as a starting point. Crystals were formed in the 
space group C222i under the following conditions 15 -  18 % PEG 4000, 0.65 -  0.85 M 
lithium chloride, and 100 mM sodium acetate buffer at pH 4.6.
Figure 5.4: Crystals of TSST-1 Y13A
Data collection and refinement
X-ray diffraction data for TSST-1 Tyr 13-Ala to 2.5A were collected at room 
temperature at the Synchrotrone Trieste protein crystallography beamline (Italy) 
equipped with a MAR345 image plate in big Mar mode. Sixty three images were
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collected at 180 sec/image, with an oscillation range of 2° per image. A second data set 
of thirty two images was collected at the SRS, Daresbury, PX 9.5 to 2.6A resolution 
using a MAR345 image plate. The exposure time was 180 sec/image and the 
oscillation range was 1.5°. X-ray diffraction data for TSST-1 His 141-Ala to 2.9A were 
collected at room temperature on beamline PX 7.2 (Daresbury, UK) equipped with a 
MAR345 image plate. Thirty images were collected in dose mode (180 sec/image), 
with an oscillation range of 1° per image. A second data set was collected at 3.0 A 
resolution using a MAR345 image plate. The exposure time was 180 sec/image and the 
oscillation range was 1.0°. Room temperature data for TSST-1 Tyr 174-Ala to 2.8 A 
was collected at the SRS, Daresbury, PX 7.2 (50 images) on a MAR345 image plate 
with 1.5° oscillation and 180 sec/image. A second dataset was collected to 2.5A on 
beamline PX9.6 equipped with a MAR345 image plate. 47 images were collected at 
180 sec/image, with an Oscillation range of 1° per image. Data processing, scaling and 
merging was performed using the HKL program suite (Otwinowski and Minor, 1997). 
The final Rmerge for TSST-1 Tyr 13-Ala was 12.6 % with an overall completeness of 
86.4%, for His 141-Ala the final Rmerge was 8.7 % with an overall completeness of 
85.1%, and for Tyr 174-Ala the final Rmerge was 11.6 % with an overall completeness 
of 85% (Table 5.1). In the case of Tyr 13-Ala and Tyr 174-Ala mutants which are 
isomoiphous with native TSST-1, phases were determined using the structure of native 
TSST-1 (Papageorgiou et al.9 1996) as a starting model, which was subjected to an 
initial round of rigid body refinement. Due to the change in space group and the 
number of molecules in the asymmetric unit seen in the His 141-Ala mutant, 
molecular replacement was performed using the crystal structure of native TSST-1 as 
the search model. AMoRe (Navaza, 1994) gave clear solutions for the two molecules 
in the asymmetric unit as follows;
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SolutionF 46.36 51.29 91.04 0.1918 0.3399 0.0865 40.2 52.0
SolutionF 37.19 109.98 248.28 0.8423 0.2182 0.8388 40.2 52.0
The structures were refined to completion by simulated annealing using tight non- 
crystallographic symmetry (NCS) restraints and the maximum likelihood target as 
implemented in the program CNS (Brilnger et al., 1998). R&cC and Royst were used to 
follow the progress of refinement (Briinger et al., 1992). At the final stages of 
refinement B-factor refinement and release of the NCS restraints were performed. For 
the Y13A and Y174A structures individual B-factor refinement was carried out and for 
H141A grouped B-factor refinement was used. SigmaA-weighted electron density 
maps (I F j - 1 F j , 2| F j - 1 F j ) were calculated after each cycle of refinement and 
visualised using the program ‘O’ (Jones et al., 1991). Water molecules were added to 
the Tyr 13-Ala and Tyr 174-Ala models towards the end of refinement with the aid of 
difference maps and the program water_pick in CNS (Brilnger, 1998). The final model 
of TSST-1 Tyr 13-Ala has a crystallographic Rfector (Rciyst) of 20.3% for all data from 
20 to 2.6A resolution, and an Rfee of 22.1% for 5% of the data omitted. The final 
TSST-1 His 141-Ala model has a crystallographic Rfector (Rayst) of 18.7% for all data 
from 20 to 3.0A resolution, and an Rfree of 19.3% for 5% of the data omitted, and the 
final TSST-1 Tyr 174-Ala structure has a crystallographic Rfector (Rciyst) of 18.5% for 
all data from 20 to 2.6A resolution, and an R&ec of 19.8% for 5% of the data omitted 
(Table 5.1).
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Figure 5.5: Diffraction image from TSST-1 Y13A (top) and TSST-1 Y174A (bottom).
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Table 5.1 Crystallographic data collection and refinement statistics
Tyr 13-Ala His 141-Ala Tyr 174-Ala
Cell Dimensions (A) a= 107.9, b = a = 126.9, b = a= 108.3, b =
175.1, c = 96.7.0 101.3, c = 82.0 176.9, c = 97.3
Space group C222i £  mol/a.u. P4i2i2 £  mol/a.u. C222| ;3 mol/a.u.
Resolution (A) 40.0-2.6 20.0-3.0 40.0-2.6
No. of measurements 90122 94387 83372
No. of unique reflections 38996 18340 32506
Completeness 86.4(76)* 85.1 (87.8)* 84.7(68.8)*
I/a 6.6 (5.0) 6.3 (3.05) 5.1 (4.1)
Rmerge (%) 12.6 (39.7) 8.7(54.9) 11.6(27.8)
Refinement
Rcryst (%)C 20.3 18.72 18.5
iW % )d 22.1 19.28 19.8
No. of protein atoms 4656 3082 4656
No. of water molecules 116 - 146
Average temperature factor(A2) 27.7 62.5 28.5
RMSD in bond lengths (A) 0.007 0.007 0.006
RMSD in bond angles (A) 1.362 1.36 1.342
Outermost shell.
b Rmerge = Z(l Ij - <I>I )/E<I>, where Ij is the observed intensity of reflection j and <I> is the 
average intensity of multiple observations.
c Ray* = Zl Fj - 1 F<J /Zl F<J, where F0 and Fc are the observed and calculated structure factor 
amplitudes, respectively.
d 5% of the data that were used for the calculation of were randomly excluded from the 
refinement.
Quality of the structures
The details of data collection and refinement for all three structures are shown in Table 
5.1. Crystals of TSST-1 Tyr 13-Ala and Tyr 174-Ala contain three molecules in the 
asymmetric unit and belong to the orthorombic space group C222i. The refined 
structure contains 194 amino acid residues (4656 protein atoms) with the Tyr 13-Ala
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structure containing 116 water molecules and the Tyr 174-Ala structure 146. The 
overall quality of the final Tyr 13-Ala and Tyr 174-Ala models as assessed by 
PROCHECK (Laskowski, 1993) are good, with 90.3% of the residues in the most 
favoured regions and no residues in disallowed regions for both structures. 
Superposition of Tyr 13-Ala monomer pair mainchain atoms gave an r.m.s. deviation 
of 0.21 and 0.23A for moll -  mol2, and moll -  mol3 respectively. The r.m.s deviation 
for Ca atoms between native and Tyr 13-Ala is 0.36A. Superposition of monomer pair 
mainchain atoms of Tyr 174-Ala gave an r.m.s. deviation of 0.25 and 0.25A for moll -  
mol2, and moll -  mol3 respectively. The r.m.s deviation for C a atoms between native 
and Y174A moll is 0.21A.
Crystals of TSST-1 His 141-Ala contain two molecules in the asymmetric unit and 
belong to the space group P4i2i2. The first three residues were not modelled due to 
poor density. The refined structure contains 191 amino acid residues (3082 protein 
atoms). The overall quality of the final model as assessed by PROCHECK (Laskowski,
1993) is good, with 82.5% of the residues in the most favoured regions and no residues 
in disallowed regions. Superposition of monomer pair mainchain atoms gave an r.m.s. 
deviation of 0.75 A for moll -  mol2. The r.m.s deviation for Ca atoms between native 
and mutant structures is 1.09 A, mainly due to differences in the regions involved in 
crystal packing. Removal of these regions from the calculation give an rms deviation of 
0.44 A.
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Crystal packing of TSST-1 Tyr 13-Ala and Tyr 174-Ala
As with native TSST-1, both the Tyr 13-Ala and Tyr 174-Ala variant forms crystallise 
with three molecules in the asymmetric unit (Papageorgiou et al., 1996). The three 
molecules are arranged such that two o f them (mol 1 and mol 3) are packed next to 
each other with the third molecule (mol 2) on the top (Figure 5.6). Mol 1 and mol 3 
form a non physiological dimer, and mol 1 and mol 2 are related to each other by a 
two-fold non-crystallographic axis (Acharya et a l , 1994). Mol 2 residues 1 5 7 -1 6 3  
(P9-pl0) are close to the concave face o f the N-terminal p-barrel o f mol 1 and between 
the pi strand and the p4 - p5 loop. There is only one hydrogen bond at the interface 
between m oll and mol2 (between Asp 160 o f Mol 2 and Arg 34 from mol 1). There are 
several van der Waals contacts between m oll and mol 2 including some water 
mediated contacts (Papageorgiou et al., 1996).
tn . o , Q>
1
Figure 5.6: The arrangement of the three molecules of TSST-1 in the unit cell of the C222t 
form.
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Molecules 1 and 3 make extensive contacts, mainly through the N-terminal residues 
119 and part of the (54 (60 -  75) and 05 (79 -  89) strands and the loop between them. 
The formation of the interface corresponds to a loss o f approximately 2000A2 of 
accessible surface area. The first 80 N-terminal residues of mol 1 and mol 3 are 
running almost parallel across the interface but in opposite directions. Part of the 04 
and 05 strands from mol 1 runs parallel to the a l  helix of mol3 and several hydrogen 
bonds are formed (Papageorgiou et a l, 1996).
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Crystal packing of His 141-Ala alternate crystal form
Interaction between the two molecules in the asymmetric unit is mediated by several 
residues all in the N-terminal domain. Residues from the p i, P2, p3, p4, p5 strands and 
the loops in between them from both molecules from van der Waals contact with each 
other (see Table 5.2).
Table 5.2: Contacts between monomer pairs in the TSST-1 H141A P4i2i2 crystal form. Cut-off 
values (A); C -C  - 4 .1 ,  C - N  = 3.8, C -O  = 3 . 7 , 0 - 0  = 3.3,0 - N  = 3.4,N - N  = 4.4.
Mol 1 residues (atom) Mol2 residues (atom) Distance (A)
Ser29 (OG) Pro 48 (CB) 3.6
Leu 30 (CD2) Pro 50 (CB) 3.8
Arg 34 (CZ) lie 46 (CD1) 3.5
Leu44 (CD1) Ser 32 (CB) 4.1
Leu 44 (CD2) lie 46 (CG2) 4.1
lie 46 (CG2) Leu 30 (CB) 3.7
Lys 70 (CD) Asp27 (OD2) 2.7
Lys 70 (CD) Ser 29 (OG) 3.5
Lys 70 (CB) Arg 34 (NH2) 3.8
Gin 73 (NE2) Arg 34 (CD) 3.7
Thr 75 (OGl) Gin 73 (OE1) 3.1
Thr 75 (CG2) He 81 (CG2) 3.7
Ser 76 (CB) Ser 76 (CB) 4.0
Glu 77 (OE2) Gin 73 (CB) 2.9
(OE1) His 74 (ND1) 3.3
lie 81 (CGI) Leu 44 (CD1) 4.1
Phe 83 (CE2) Arg 34 (NH1) 3 2
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The total buried surface between monomer pairs is 1481.4 A2. Due to the low 
resolution o f the structure (3.0A) it is unclear what part water molecules may play in 
mediating the contacts between the two monomers. The monomers pack together N -  
terminal p barrel to N -  terminal P barrel (Figure 5.7). The ?4\2\2  crystal form is 
unique to TSST-1 His 141-Ala and as a crystallographic dimer represents a new 
structure.
Figure 5.7: The crystal structure of TSST-1 variant H141A as a crystallographic 
dimmer. Interaction between the two monomers is mediated by several N-terminal 
domain residues.
Overall structure
The three TSST-1 mutant structures are essentially the same as native TSST-1 in 
architecture (Papageorgiou et a l ,  1996). All three comprise o f an N- and C-terminal 
domain packed together to form a compact molecule o f approximately 45 A X 45 A X 
58A. Despite the low sequence identity with other superantigens (less than 28%), the
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overall structure of TSST-1 and subsequently these three variants is remarkably similar 
to other superantigens (see Chapter 2). However, TSST-1 exhibits several structural 
differences. It is 45 residues shorter than SEB and SEC2, and 39 residues shorter than 
SEA, mainly due to deletions in several loop regions and the absence of a disulphide 
loop (Papageorgiou et al., 1996).
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Effects of mutation
The density for the sidechains at the three mutation sites (Tyr 13, His 141, and Tyr 
174) are shown below (Figure 5.8A, B, C). The 2|F0| -  |FC| maps contoured at 1 a  
clearly show density for the substitute alanines only.
A
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Jfci
c
Figure 5.8: Sidechain density at the three mutation sites. A Tyr 113, B His 141, C Tyr 174.
Native structure are shown in light grey, mutant structures in light grey. 2|F0| -  |FC | map 
contoured at 1 a.
Tyr 13-Ala effects of the mutation
In the native structure, Tyrl3 is solvent-inaccessible and participates in hydrogen bond 
formation with Asp 130 and His 135 (Papageorgiou et al., 1996) and as such is strongly 
implicated in the overall architecture o f the site (Figure 5.9). In a previous study 
mutation o f Tyrl3 to leucine resulted in a toxin with no ability to stimulate human T 
cell hybridoma cells, but still able to bind MHC class II molecules (Hurley et al.,
1995). O f the residues that contact Tyrl3, His 135 has been shown to be o f great 
importance for the overall structure and activity o f the toxin (Papageorgiou et al.,
1996), (Bonventre et al., 1993). Mutation o f  His 135 to alanine results in the loss o f T 
cell mitogenicity and also loss o f toxicity in animal models (Bonventre et al., 1993).
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Figure 5.9: The interactions between Tyr 13 and the a  2 helix. Native structure is shown 
in light grey, mutant in dark grey.
His 135 (a2 helix) is thought to be directly involved in TCR interaction and in the 
HI 35 A mutant structure its replacement with alanine results in perturbation o f the 
neighbouring a l  helix through loss o f helix -  helix interaction. However, the 
conformation of Tyr 13 is preserved in H135A by a stabilising H-bond with Trpl2 and 
aromatic interaction with Asp 130 (Papageorgiou et a l ,  1996). Clearly, the interaction 
between a l  and a2 helices is o f great importance for TSST-1 with regards to TCR 
recognition.
In the mutant structure the loss o f several interactions between the a l  and a2 helices 
causes the Ca backbone to move by 1.5 A (away form the a2 helix) between residues 
14 to 18 (the bottom o f the a l  helix). The H-bond between residue 13 mainchain O
127
Chapter 5 Toxic shock Syndrome toxin -1 mutants
atom and His 135 sidechain is lost (the distance is 3.46A compared to 2.7 A in the 
native structure) as well as the H-bond between the Tyr 13 sidechain and Asp 130 
( 5.2 A compared to 2.89 A, see Figure 5.9)
Although contacts are preserved between residues in the a l  helix region (Ser 15 and 
Gly 16) and Lys 67 in the p4 strand. Ala 13 is in contact with two water molecules, 
also present in the native form which may function to stabilise the mutation site.
Figure 5.10 shows a close up view of the TSST-1 TCR binding site including the 
location of the Tyr 13 and His 135 sidechains. The architecture of the site can be 
considered in two ways, firstly in terms of those residues thought to make direct 
contact with the TCR Vp chain, such as Thr 128, His 135, Gin 139, and lie 140 
(Papageorgiou et a l, 1996) and secondly, in terms of those residues that maintain the 
overall structure of the site allowing optimal contact between TCR and TSST-1, as is 
the case for Tyr 13.
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Figure 5.10: A close up view of the TSST-1 TCR binding site. The residues changed in 
the three variant structures are shown in ball-and-stick representation, along with residue 
His 135.
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H141-Ala effects of the mutation
The most immediate change in the structure o f TSST-1 His 141-Ala compared to 
native TSST-1 is the movement o f the (34 strand (residues 74 -  80) by -7.8A . The p4 
strand is thought to be involved in MHC class II recognition (Papageorgiou et al.,
1996). In the His 141-Ala structure this region is located at the interface between the 
two monomers and is involved in packing. The region encompassing the p6 - p7 loop 
and part o f p7 is also shows some movement (Figure 5.11) probably due to crystal 
packing.
The region at the end o f  the a2 helix, residues 139 through to 150, including His 141 
also shows some deviation from the native structure (5.11) movement is up to -1 .5  A 
away from the a l  helix. Whilst the a l  helix also shows some deviation from that of  
the native structure.
Figure 5.11: The Ca trace of native (dark grey), Y13A (green), Y174A (blue), and 
H141A (red) forms of TSST-1.
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In the native structure, His 141 is located close to the C-terminal end o f the a2 helix 
and is also inaccessible to solvent (Papageorgiou et al., 1996). It is hydrogen bonded to 
Gin 136 and Ser 111 (Figure 5.12). Several studies have examined the importance o f  
His 141 and its surrounding residues for TCR recognition (Bonventre et a l ,  1993) 
(Deresiewicz et al., 1994). His 141-Ala mutants were found to exhibit only half 
maximal activity, whilst the double mutant H141/Y144A was devoid o f mitogenic 
activity (Bonventre et al. , 1993). However His 141-Ala variant toxin still caused lethal 
shock in rabbits. Mutations in this area seem to interfere in TCR recognition.
Figure 5.12: Comparison of the interactions of residue 141 in native (light grey) and 
mutant (dark grey) forms. All residues are labelled.
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In the His 141-Ala structure both hydrogen bond contacts to Gin 136 and Ser 111 are 
lost The local area is stabilised somewhat by van der Waals interaction between Ala 
141 and lie 193 (Figure 5.12). It is not clear at this resolution what contribution water 
molecules may make to the stabilisation of the mutation site. Solvent accessibility 
calculation using the program DSSP (Kabsch and Sander 1983) indicates that the 
mutation site is inaccessible to solvent
It is interesting to note that His 141 falls in a region described by Arad et al (2000) and 
Visvanathan et al (2001) that defines a peptide protective against superantigen 
mediated shock both in terms of a vaccine and as a therapy (see Chapter 2 for more 
details). Although this residue may not be directly involved in TSST-1 TCR binding, it 
is clearly in an area of significant structural importance and high immunogenicity.
Effects of the mutation Tyr 174-Ala
In the native structure Tyr 174 is located at the start of the 3io helix which lies 
immediately on top of the TCR site. It forms several contacts with other residues 
including Tip 12 from the a l  helix and Ser 127 from the a2 helix, both of which form 
part of the TCR binding site. Tyr 174 is orientated into the TCR binding site towards 
other TCR binding residues (Figure 5.10). It also makes contact with residues Pro 48 
and lie 85, both of which are implicated in MHC class H recognition (Papageorgiou et 
a l , 1996). In the Tyr 174-Ala structure Ala 174 makes almost no contact with any 
other residues (Figure 5.13). The mutation site is stabilised by the preservation of the 
contacts in the surrounding residues both with each other and with other parts of the 
toxin. Lys 171 makes contact with Trp 12, Phe 172 contacts Ser 127, Aspl30 and Arg 
134. Asn 176 contacts Ala 125 and lie 126. AH of these residues are located in either 
the a l  or a2 helix.
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Tyr 174 Ala
Serl27
Figure 5.13:Comparison of the interactions of residue 174 and its neighbouring residues.
The native structure is shown in light grey, the mutant structure in dark grey.
Two water molecules that are seen in the area o f the mutation site in both the mutant 
and native forms may contribute to the overall stability o f this region.
The interactions between this 3 io helix and the classically defined TCR binding site 
may identify a possible role for this region in TCR recognition. Whether this role is 
structural, in terms o f stabilising the TCR site, or functional, in terms o f forming direct 
contact with the TCR remains to be seen. Clearly further work needs to be done in 
order to further assess the contribution o f this residue and the rest o f the 3io helix in 
TCR recognition.
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Summary
TCR recognition among bacterial superantigens can be described both in terms of those 
residues that make direct contact with TCR Vp and in terms of those residues that 
preserve the conformation of the binding site. Differences among the Vp population 
mean that whilst a core of these residues may be constant for interaction with all Vp 
subtypes, other residues will be specific for determining the particular Vp specificities 
of each superantigen. As each superantigen binds several Vp subtypes, these residues 
may differ for each Vp type.
Binding studies and T cell proliferation experiments may give us useful information on 
residues that effect T cell recognition and activation; Similarly, the crystal structures of 
TCR binding site mutants help us to understand theses effects. But, without crystal 
structures of each mutant in complex with each TCR Vp subtype, it is not possible to 
conclusively determine the contribution of each of these residues to TCR Vp 
recognition.
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Introduction
The crystal structure o f native SEC2 revealed a zinc binding site located between the 
two domains o f the toxin (Figure 6.1). The site is formed by residues Asp 83, His 118, 
His 122 and Asp 9 from a symmetry related molecule which is most likely replaced 
with a water molecule under biological conditions (Figure 6.2) (Papageorgiou et al., 
1995) (Schade/a/., 1997).
The zinc site in SEC2 is superimposable with that o f SEA (Schad et al., 1995), SpeAl 
(Baker, 2001), and SED (Sundstrom et al., 1996) but differs somewhat in its 
coordination geometry.
Figure 6.1: The crystal structure of native SEC2. All secondary structure elements are 
labelled. The zinc ion is represented by a blue sphere.
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The residues in the SEC2 zinc correspond to Asp 77, His 106, and His 110 in 
SpeAl with the fourth ligand being Glu 33, (Baker et al., 2001), and also has analogous 
residues in SEA (Schad et al., 1997), and SED (Sundstrom et al., 1996).
Figure 6.2: A close up view of the zinc binding site of SEC2. All ligands are labelled.
The zinc ion has been shown to be an intrinsic part o f SEC2 with a dissociation constant 
o f lpM  (Papageorgiou et al., 1995) and is situated at some distance to the generic 
binding site on the opposite side o f the toxin.
The role o f zinc in high affinity MHC class II binding is now well established and in the 
case o f SEC2 represents an alternate mode o f MHC class II binding to its generic MHC 
class II binding site (Papageorgiou et al., 1995; Li et al., 2001; Petersson et a l , 2001 ).
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Mutant selection criteria and aims
The two SEC2 variants SEC2 H122A and HI 18:122A contain substition of histidine 
residues identified as zinc ligands in the native structure of SEC2 (Papageorgiou et a l , 
1995). Kumaran et al., (2001) attempted to determine the structural contribution of both 
the zinc binding histidines by determining the structure of SEC2 at various pHs by the 
molecular-replacement method. Two different crystal forms were found, tetragonal (pH 
5.0,5.5,6.0 and 6.5) and monoclinic (pH8.0). Below pH 6.0 it was thought that these 
zinc co-ordinating histidines would be protonated and the zinc leached out However, in 
the two lowest pH structures solved (pH 5.0 and 5.5) a zinc ion was still found to be 
present. Both the B factors and the co-ordination geometry increased at low pH; the 
bond distance for His 118 -  zinc increased by 0.38 A  and for His 122 the bond length 
increased by 0.28A.
The aims of these experiments were to express and purify both SEC2 H122A and 
HI 18:122A, followed by their crystallisation and structure determination. By studying 
the effect of mutation of both these histidine residues to alanine it is hoped to further 
understand the nature of the SEC2 binding site; how it interacts with MHC class II 
molecules, and the contribution that each of the zinc-binding residues make to the zinc 
site.
Materials and methods 
Over-expression of SEC2 H122A and H118:122A-DE3 clones.
pET30a7SEC2H122A and pET30aSEC2Hl 18:122A cloned in JM109(DE3) were 
obtained from CAMR. The pET30a vector contains a T7 promoter, a His tag with both
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an enterokinase and factor Xa cleavage site and is immobile. Point mutations were 
introduced into the SEC2 gene by PCR with oligonucleotides containing the desired 
nucleotide substitution, and the genes inserted into pET30a.
Cultures were grown in as follows;
200ml flasks containing 50ml of LB supplemented with 1% glucose, 100 pg/ml 
ampicillin were Inoculated with either SEC2H122A or SEC2H118:122A clones and 
incubated overnight at 37° C with shaking. These 50 ml starter cultures were then 
transferred into 11 flasks, with 500ml LB, 1 % glucose, 100 pg/ml ampicillin and 
incubated at 37° C until the optical density reached + 0 .7 -1 .0  au (600nm). Expression 
was induced with IPTG at 100 pm/ml IPTG for H122A ( 0.2 ml/litre) and 0.5 mM per 
ml IPTG for HI 18:122A (1.0 ml/litre) and the flasks incubated for a further 2 - 3  hours 
at 37°C. Cells were collected by centrifugation at 5000rpm for 25 minutes.
Purification was carried out as described in the pET system manual (Novagen). Briefly, 
cell pelletes were re-suspended in a total volume of 10 ml of binding buffer and 
transfered to tubes suitable for sonication. Five rounds of sonication were carried out at 
14 microns for 30 seconds followed by 1 minute rest on ice. Samples were then 
centrifuged at 15,000 rpm for 15-20 minute using RC-5B centrifuge and SS34 rotor. 
Samples of cleared lysate were then loaded onto an equilibrated Nickel-NTA His-Bind 
column (Novagen) and the flow through collected for further analysis. The column was 
then washed with twice with wash buffer and eluted in 5 ml of elution buffer. All 
fractions were saved for further analysis by SDS gel.
Factor Xa His tag cleavage
The pooled purified toxin fractions were dialysed for 24 hours against two changes of 
cleavage buffer (20mM Tris-HCl, 100 mM NaCl, 2mM CaCb at pH 8.0). Cleavage was 
carried out at 23°C for 24 -  48 hours using 5 pg of factor Xa per mg of protein as
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assessed by absorbance at 280 nm. Purified cleaved protein was obtain by reapplying 
the sample to the His bind column and collecting the run through.
Immunodiffusion as a way of assessing the presence and 
concentration of toxin.
0.5g of powdered agar was added to 50 ml of purified distilled water and heated using a 
microwave oven to produce a 0.1% agar solution. After cooling, 150 pi of lmg/ml 
guinea pig anti-SEC2 was added and the agar was then poured into 20 ml plates and left 
to set at 4°C. Two rows of 5 mm diameter wells were then cut at the top and bottom of 
the plates. In the top row 25 pi of serial dilutions of native SEC2 were added as a 
standard, and the samples to be assessed were added to the bottom row. Plates were then 
left overnight at 4°C. A standard curve was plotted of the square of the diameter of the 
halo produced by the interaction between SEC2 and antibody against the concentration 
o f SEC2. Sample concentration was calculated using the standard curve.
Mono-S column
Cell pellets were re-suspended in 2ml of 50 mM sodium acetate and sonicated at 14 
microns for 5 x 30 seconds interspersed with 1 minute rest on ice. The lysed cells were 
then spun at 13,000 rpm for 5 minutes and the lysate applied to a Mono-S column 
equilibrated with 50 mM sodium acetate. The column was washed with 50 mM sodium 
acetate and the protein eluted on a 0 -  30% 1M NaCl gradient 1 ml fractions were 
collected throughout and analysed by spectrophotometer at 280 nm.
Mono-Q column
Cell pellets were re-suspended in 2ml of 20 mM Tris (pH 8.0) and sonicated at 14 
microns for 5 x 30 seconds interspersed with 1 minute rest on ice. The lysed cells were 
then spun at 13,000 rpm for 5 minutes and the lysate applied to a Mono-Q column
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equilibrated with 20 mM T ris. The column was washed with 20 mM Tris and the 
protein eluted on a 0 -100%  1M NaCl gradient 1 ml fractions were collected 
throughout and analysed by spectrophotometer at 280 nm.
Red A column
For a detailed method of purification of staphylococcal enterotoxins using red A see 
(Brehm et a l, 1990). Briefly, 5 ml of Red A was poured into a 5 ml column 
(pharmacia), washed with 10 mM phosphate buffer (pH 6.5) and left to settle. The 
column was then cleaned with seven volumes of 8 M urea containing 0.5M NaOH, and 
equilibrated with 10 mM phosphate buffer (pH 6.5). The sample was then applied to the 
column which was again washed with 10 mM phosphate buffer at pH 6.5 until the A280 
level of flow-through reached a baseline level. The fusion protein was eluted with 
stepwise increases in KC1 concentration (using 10 mM phosphate buffer containing 35 
mM KC1 at pH 6.5). 1 ml fractions were collected throughout and analysed by 
spectrophotometer at 280 nm.
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Results and Discussion
Figure 6.3 A, B, and C show the stages o f purification of SEC2 H122A. A majority o f  
the toxin binds to the column (figure 6.3A lanes 3 and 4) although approximately half o f  
it is eluted in the wash fraction (3), perhaps due to overloading o f the column.
(4 ) Eluted (3) colum n (2 ) flow  
Protein wash through
1) crude 




Figure 6.3: The purification of SEC2 H122A. A: purification of fusion protein using 
His bind resin A) Initial purification of fusion protein. B) Cleavage of fusion protein 
using factor Xa. Digest at 24 hours and 48 hours. The upper arrow points to the 
uncleaved fusion protein whilst the lower on indicates the cleaved toxin C) purified 
cleaved toxin in 1:5 serial dilution (left to right).
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This fraction was collected, dialysed against PBS and reapplied to the column in order 
to maximise the yield. The fourth lane in Figure 6.3 A shows that the His bind column 
allows a relatively pure sample to be obtained. The pooled purified fiision protein 
samples underwent factor Xa cleavage for 48 hours (Figure 6.3B). After 24 hours the 
cleavage reaction was not complete so the sample was left a further 24 hours. It is 
important to note that the cleaved samples in lanes 2 and 3 are diluted by approximately 
12 times compared to the fusion protein sample in lane 1. The cleaved His tags were 
removed by reapplying the sample to the column. Figure 6.3C shows three successive 
1:5 serial dilutions of the purified toxin on an SDS gel to illustrate its purity.
Toxin concentration as assessed by absorbance at 280 nm was 26 mg and by 
immunodiffusion 25 mg.
Figures 6.4A and B show the attempted purification of the SEC2 HI 18:122A double 
mutant From Figure 6.4A it appears that the fusion protein does not bind to the column 
and is eluted in the two wash steps. Upon rescanning the gel and adjusting the 
brightness and contrast levels it became apparent that a great amount of the fusion 
protein was also running straight off the column in the flow through from loading. Also, 
a second band is shown that corresponds to the cleaved toxin, suggesting that some 
degradation may be taking place. In order to remedy this, it was decided to lower the 
concentration of imidazole in the washing buffers from 480mM to 240mM in order to a 
allow as much toxin to bind as possible.
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Eluted wash 2 wash 1 
Protein
Eluted wash 2 wash 1 run crude 
Protein through extract
Figure 6.4: His bind purification of SEC2 HI 18:122A mutant. A) Right to left, crude cell extract, 
column run through, wash 1, wash 2, eluted protein. B) Re-scan of A with increased brightness 
and contrast levels
Decreasing imidazole concentration proved unsuccessful. As a result it was decided to 
re-sequence the HI 18:122A fusion protein gene to determine that the His tag was 
present in its correct form.
AAT AT GC ACC ATC ATC ATC ATC ATC ATTCT
The sequence clearly shows the presence o f coding sequence for 6 histidine residues 
and a band is produced on the gel o f the correct size for the fusion protein which 
suggests that there may be something else effecting its binding to the nickel column. 
Consequently, it was decided to try other methods to purify the fusion protein: a mono- 
S column, a mono-Q column and a red A column.
Preliminary trials with a mono-S column failed to bind any protein at all to the column. 
This method has been used previously to purify native SEC2 in the CAMR laboratories 
and relies on the sample having a low salt content. The experiment was repeated using
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samples dialysed against loading buffer for 24 hours in order to minimise salt content. 
Again, all of the protein came through in the run through from loading the column. 
Conversely, the fusion protein bound to the mono-Q column, but could not be eluted; 
even at 1 M NaCl. Indeed, it was only removed from the column by 8 M urea.
The red A method of toxin purification also failed to produce any further results. The 
fusion protein yet again failed to bind to the column. Red A has been used very 
successfully in the past to purify native SEC2 (Brehm et a l , 1990) indicating that the 
nature of the fusion protein differs from that of native SEC2.
Preliminary crystallisation trials with SEC2 His 122-Ala
Initial crystallisation trials were set up using the conditions used for native SEC2 
(Papageorgiou et a l, 1995); 25 -  28% PEG 8000,0.15 M ammonium sulphate, 0.02% 
(w/v) sodium azide and 0.1 M cacodylate buffer. However, these conditioned failed to 
produce any crystals. Hampton research crystal screen and PEG/ion screen were also 








The crystal structures of SpeAl in complex with zinc, SEB variant Thr 112-Ser, and the 
three TSST-1 mutants Tyr 13-Ala, His 141-Ala, and Tyr 174-Ala presented here, 
combined with the wealth of structural and biological information available illustrate 
that although a fundamental set of structural features exist among the superantigen 
family, subtle differences exist among the functional mechanisms of each toxin.
The zinc site identified in SpeAl is one such common feature. The zinc ligands are Glu 
33, Asp 77, His 106, and His 110; the residues Asp 77, His 106, and His 110 are 
structurally equivalent to the residues Asp 83, His 110, and His 122 in SEC2, whilst Glu 
33 is unique to SpeAl as a zinc ligand. Further diversity exists as some toxins have 
multiple zinc sites with differing affinities for MHC class II molecules as well as a 
generic MHC class II site (SEC2, SED, SEA). In some toxins the zinc ion may be used 
for dimer formation (SpeC, SEA), whilst other toxins have a single zinc site in 
combination with a generic MHC site (SpeAl), or simply a zinc site and no generic 
MHC site (SEH). Questions remain about the use o f zinc in dimer formation which will 
be addressed in chapter VIII. Neither SEB or TSST-1 posses a zinc site, yet are both 
extremely potent and simply rely on a generic MHC binding site for interaction with 
MHC class II molecules. Further regulation is provided by the nature of the antigenic 
peptide in the peptide binding groove of the MHC class II molecule.TSST-1 in complex 
with MHC class II exhibits extensive contact with the antigenic peptide. Indeed, TSST- 
1 presentation by MHC class II molecules has been shown to be enhanced or 
diminished depending on the composition of the antigenic peptide. The SEH -SpeC - 
MHC II complex structures indicate that extensive contact with the peptide is also made 
during zinc mediated SAg/MHC II interactions, which could allow some aspect of 
peptide control to SAg presentation.
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The multiplicity that exists within the toxin family with regard to TCR binding can be 
described both in terms of those residues that support the architecture of the TCR 
binding site and in terms of those residues that bind directly to the TCR. This can be 
further subdivided into those residues that form a common core of TCR binding 
residues and those that govern specificity of binding to TCR Vp elements. The structure 
of SEB Thr 112-Ser highlights the role that structural residues play in maintaining the 
integrity of the TCR binding site and how such residues can affect the strength and type 
of response. The three TSST-1 mutants Tyr 13-Ala, His 141-Ala, and Tyr 174-Ala 
illustrate that further diversity exists among the family as the TCR binding site is 
located in a different position in the toxin. Again, these structures have highlighted the 
contribution that certain residues can make to maintaining the integrity the TCR binding 
site. Additional differences are also found between TSST-1 and the other members of 
the superantigen family. It does not possess a disulphide loop which is thought to cause 
emesis. This is consistent with its role in TSS.
Various combinations of generic and zinc mediated MHC class II binding sites and the 
slight differences between the toxins in other functional regions such as the TCR site 
would allow each toxin to modulate the immune system in an appropriate manner. For 
example, the 3-dimensional structure of SpeAl illustrates that it has the potential to act 
as a monomer or dimer, and can use a generic or zinc MHC class II binding site or 
perhaps both. The use of these elements may vary within the context of the disease. 
Subtleties within the finer points of their mechanism such as those illustrated by the 
SEB Thr 112-Ser variant could propagate different strengths, quality, and quantity of 
response by different T cells bearing different TCR Vp elements. In turn this may 
facilitate TCR clustering giving rise to a more apposite response.
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Chapter Eight Structural and Functional Studies on Microbial Superantigens
Within the scope of this project further work is imperative. In order to fully characterise 
the three TSST-1 mutants additional biological work needs to be performed. The 
crystallisation and structure solution of the SEC2 mutants, along with biological studies 
would help us further understand the nature of zinc mediated MHC class II binding. 
Beyond this, several additional crystallographic and biological experiments would 
greatly enhance our understanding of the mechanics of superantigenicty. By studying 
the nature of the toxin in the context of the MHC class II -  SAg -  TCR complex: the 
crystal structure of the tri-molecular complex of toxin TCR and MHC may show some 
features that are not apparent from either SAg -  MHC or SAg -  TCR complex alone. 
Such features are not likely to be deduced from modelling. Further to this, 
investigations into multiple complexes of toxin(s) and MHC and TCR would illustrate 
the mechanics of receptor clustering for TCR and dimer formation for superantigens. By 
examining the conditions under which dimerisation and/or zinc ions are used by each 
toxin further light would be shed onto the strategies used by each toxin to produce an 
optimal affect under differing conditions. These multiple mechanisms may well act as a 
kind of self-regulatory element within each toxin so as to elucidate a distinct response 
from the immune system to allow the causation of disease. Superantigens are implicated 
in many different diseases and a comprehensive study of how their role changes within 
the context of different diseases may further increase our understanding of the disease 
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